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ABSTRACT
Fishbein, Cassandra R. DNP. Miami Valley-College of Nursing and Health, Wright
State University/University of Toledo, 2017. Screening Mothers for Postpartum
Depression at Well-Child Visits in a Private Pediatric Clinic: An Evidence-Based
Practice Improvement Project.
Postpartum depression (PPD) affects approximately 10-15% of women and can have
serious negative effects on mothers, infants, and families. PPD can persist throughout
the first year after delivery when mothers no longer have consistent contact with their
primary health care provider. The U.S. Preventive Services Task Force, the American
Congress of Obstetricians and Gynecologists, the American Academy of Family
Physicians, and the American Academy of Pediatrics recommend screening for
depression when support systems are in place to ensure referral for further evaluation,
diagnosis, and treatment. Pediatric providers have consistent interactions with
mothers and infants during well-child visits. During this evidence based practice
improvement project, a screening program for depression was implemented using the
Edinburgh Postnatal Depression Scale (EPDS) at the 2 week, 2 month, 4 month, 6
month, well-child visits. Mothers who screened positive were provided community
resources and referred to their primary care provider. The Evidence-Based Practice
Improvement Model (EBPI) guided this project. Eight pediatric providers, seven
licensed practical nurses (LPN), two receptionists, and the office manager were
educated on the significance and risks of PPD, the effectiveness of PPD screening, the
use of the EPDS, and steps to take when the screening indicated a risk for PPD was
present. A total of 255 mothers were eligible for screening and 160 mothers (67%)
completed the EPDS during the three month implementation period. Documentation
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of the screening and distribution of resource packets and referrals given to mothers
occurred at a nearly 100% rate. In addition, demographic information including
mother’s age, mother’s race, marital status, age of infant, gestational age of infant,
method of feeding, and type of insurance was also collected. Providers, staff, and
patients in this clinic benefited from education on PPD and screening continues to be
included in the selected well-child visits. Implementation of PPD screening in other
settings is indicated to demonstrate the effectiveness of identifying mothers with PPD.
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I. INTRODUCTION
Problem
Postpartum depression (PPD) is a serious complication with significant
adverse effects on maternal bonding, the emotional and behavioral development of
infants, and parenting (Olson, Dietrich, Prazar & Hurley, 2006). It is estimated that
10% to 15% of women suffer from PPD and their symptoms often occur after hospital
discharge and when they are no longer being seen by their healthcare provider
(Liberto, 2012). Apter-Levy, Feldman, Vakart, Ebstein, and Feldman (2013) explain
that longitudinal studies have revealed that children whose mothers are diagnosed
with PPD are at greater risk for anxiety, depressive and oppositional conduct
disorders, as well as maladaptive social behavior. In a study conducted by Quevedo
et al. (2011) infants of mothers with persistent depression had lower scores on
language scales at 12 months of age compared to infants whose mothers did not have
depression. The serious negative effects on mothers and infants necessitate the
crucial need for early recognition and treatment of PPD. Chaudron, Szilagyi,
Kitzman, Wadkins, and Cornwell (2004) assert that the only regular health care
contact by new mothers is during well-child visits. In fact, if all recommended well
child visits are completed the new mother will have contact with a pediatric health
care professional at least eight times in the child’s first two years (Liberto, 2012).
Maternal depression is a term that includes a spectrum of depressive
symptoms that can affect mothers-to-be and mothers up to 12 months postpartum.
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This includes prenatal depression, “baby blues,” postpartum depression, and
postpartum psychosis.
Prenatal depression can occur any time during pregnancy and can affect 10 to
20% of expectant mothers. It can persist for six to 12 months after pregnancy and
includes symptoms such as anxiety, fatigue, sleep disturbances, changes in appetite,
and irritability (National Institute for Healthcare Management, 2010).
Pregnancy, labor and delivery, and caring for a newborn can be physically,
mentally, and emotionally draining experiences for women. As many as 80% of new
mothers’ experience what is referred to as “baby blues” or “postpartum blues” with
symptoms including crying, sadness, anxiety, irritability, insomnia, and mood lability
(National Institute for Healthcare Management, 2010).
Postpartum depression affects between 10 to 15% of new mothers and can
initially be indistinguishable from “baby blues.” It typically manifests within the first
two to three months postpartum and symptoms may include persistent sadness, poor
concentration, feelings of worthlessness and guilt, irritability, anhedonia, fatigue,
insomnia or hypersomnia, somatic symptoms, poor bonding with the infant, and
recurrent thoughts of death or suicide (National Institute for Healthcare Management,
2010).
Postpartum psychosis occurs much less frequently affecting one to two out of
1,000 mothers. It most often manifests in the first two to four weeks after delivery but
can occur any time during the first year. Symptoms include auditory and visual
hallucinations, paranoia, anxiety, agitation, insomnia, mania, suicidal or homicidal
thoughts, and bizarre delusions or commands to harm the infant (National Institute for
Healthcare Management, 2010). Table 1 provides a comparison of postpartum blues,
postpartum depression and postpartum psychosis.
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Table 1
Postpartum Blues, Postpartum Depression and Postpartum Psychosis Symptom
Comparison
Postpartum Blues
Postpartum Depression
Postpartum Psychosis
Affects up 80% of new
mothers
Crying

Affects between 10-15%
of new mothers
Persistent sadness

Sadness
Anxiety

Poor concentration
Feelings of worthlessness
and guilt
Irritability
Anhedonia
Fatigue
Insomnia

Irritability
Insomnia
Mood lability

Hypersomnia

Affects one to two out of
1,000 new mothers
Auditory and visual
hallucinations
Paranoia
Anxiety
Agitation
Insomnia
Mania
Suicidal or homicidal
thoughts
Bizarre delusions or
commands to harm the
infant

Somatic symptoms
Poor bonding with infant
Recurrent thoughts of
death or suicide
(National Institute for Healthcare Management, 2010)
In addition to the psychological burden of PPD there is also a financial burden.
Although the precise cost of PPD in the United States is not known, the overall cost of
depression among the entire population is significant. In 2000, the total cost for
depression was $83.1 billion dollars. This includes $26.1 billion for direct medical
costs, $5.4 billion for suicide-related mortality costs and $51.5 billion for associated
workplace costs (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015). In addition,
the children of mothers with postpartum depression utilize health care services more
frequently adding additional costs to the health care system (National Institute of
Health Care Management, 2010). Identification of PPD and referral to appropriate
resources has the potential to improve the health and quality of life for mothers,
children, and their families while also reducing the cost of depression on society.
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The U.S. Preventive Services Task Force (2015) recommends screening all
adults for depression when support systems are in place to ensure referral for further
evaluation, diagnosis, and treatment. Both the American Congress of Obstetricians
and Gynecologists (2015) and the American Academy of Pediatrics (2010) have
issued position statements and recommendations for screening women for postpartum
depression that are consistent with the U.S. Preventive Services recommendations.
Data for Ohio collected through the Pregnancy Risk Assessment Monitoring
System (PRAMS) in 2009-2011, shows that 12. 4% of mothers in Ohio experienced
symptoms of PPD while 11.5% of mothers in the Dayton area experienced these
symptoms (Ohio Department of Health, 2015).
The negative effects of PPD for mothers, neonates, infants, and families is
well-documented. Symptoms of PPD can present at any time during the first year after
delivery. Postpartum mothers and their infants have frequent contact with pediatric
providers at well-child visits within the first year of life. One plausible solution for
early identification of PPD is to screen for PPD at well-child visits with subsequent
referral of mothers to the appropriate level of care.
Purpose and Goals
To address this clinical problem and to guide the search for relevant
information, a PICOT question was developed. A well-developed PICOT (Patient
population, Intervention, Comparison intervention, Outcome, and Time) question
assists in guiding the literature search to obtain the most relevant information
(Fineout-Overholt & Stillwell, 2015). The question used to guide the literature search
was “In postpartum mothers who bring neonates and infants for well-child visits
during the first year after delivery, how does postpartum depression screening by
pediatric health care providers compared to no screening affect identification of PPD
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and provision of community resources and referrals to the mother’s primary care
provider over a 3-month period.” A neonate is defined as a child under 28 days of age
(World Health Organization, 2016) and an infant is a child up to one year of age
(Centers for Disease Control and Prevention, 2016). The American Academy of
Pediatrics (2016) recommends well-child checks for neonates and infants at three to
five days, two weeks, two months, four months, six months, nine months and 12
months of age.
The purpose of this evidence-based improvement project was to implement a
PPD screening program for mothers who bring their infants for well-child visits,
during the first year of life, at a private pediatric practice. The goals of the project
included identifying mothers at risk for PPD and providing them with community
resources and referrals to their primary care provider for further evaluation and
treatment.
Guiding Framework
The model selected to guide this project was the Evidence-Based Practice
Improvement (EBPI) model presented by Levin et al. (2010). A unique characteristic
of this model is that it combines two existing models, evidence-based practice (EBP)
and performance or practice improvement (PI). Each of these models has been used
in health care to implement quality improvement and EBP projects. The EBPI model
focuses on formulating a precise clinical question which guides the review of the
research literature, and then critical appraisal of the evidence based on its level,
quality and significance towards a practice change. Designing and implementing the
practice change; implementing, testing and evaluating the change; and finally,
disseminating the results of the change is the focus of the PI model. In combining
these two practices, EBPI provides practitioners with a practical model which guides
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a project from describing the problem and formulating the clinical question to the
dissemination of the results.
The seven steps of the EBPI model include: describe the problem, formulate
focused clinical question, search for evidence, appraise and synthesize evidence,
develop aim (goal) statement, plan-do-study-act cycles, and disseminate best practices
(Levin et al., 2010). The problem identified for this project was postpartum
depression (PPD) and the potential negative effects on infant development.
Identification of the problem led to development of the PICOT question, a search for
relevant evidence and an appraisal and synthesis of the literature. The model guided
development of an aim statement, plan-do-study-act cycles and dissemination of best
practices throughout the project.
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II. EVIDENCE
Search for Evidence
Databases searched for relevant literature in answering the PICOT question
include The Cochrane Library, CINAHL and MEDLINE via PubMed. The key words
“postpartum depression”, “post partum depression”, “postnatal depression”, “post
natal depression”, “screen”, “screening”, “diagnose”, “diagnosis”, “diagnoses”,
“nursing”, “nurse”, “physician”, “clinician”, “pediatric”, “paediatric”, “provider”,
“health professional”, “healthcare professional”, and “health care professional” were
used when searching the databases. Criteria for inclusion were systematic reviews,
meta-analysis, randomized controlled trials and any other quantitative or qualitative
research designs, in English, published in the past 15 years. Research that considered
women during the first year after giving birth was also included. Criteria for
exclusion was research that studied women with other psychological disorders or in
high-risk situations, foreign-born postpartum women in the United States and
postpartum women with infants diagnosed with high-risk conditions. Practice
recommendations from professional organizations as well as clinical practice
guidelines were also included.
Results from the search of The Cochrane Library resulted in seven hits, none
of which met the inclusion criteria. There were eight hits in the Database of Abstracts
of Reviews and one article which met the inclusion criteria.
CINAHL was first searched with the key words “postpartum depression”,
“post partum depression”, “postnatal depression” and “post natal depression” which
resulted in 4,035 hits. Keywords searched next were “screen”, “screening”,
7

“diagnose”, “diagnosis”, and “diagnoses” which resulted in 490,285 hits. The final
set of keywords searched were “nursing”, “nurse”, “physician”, “clinician”,
“pediatric”, “paediatric”, “provider”, “health professional”, “healthcare professional”
and “health care professional” which resulted in 699,321 hits. Combining the three
searches and applying the limits of English language and research article resulted in
108 hits, of which 15 articles met the inclusion criteria. Controlled vocabulary was
not used in this search.
MEDLINE via PubMed was first searched with the key words “postpartum
depression”, “post partum depression”, “postnatal depression” and “post natal
depression” which resulted in 6,624 hits. Keywords searched next were “screen”,
“screening”, “diagnose”, “diagnosis”, and “diagnoses” which resulted in 8,540,397
hits. The final set of keywords searched were “nursing”, “nurse”, “physician”,
“clinician”, “pediatric”, “paediatric”, “provider”, “health professional”, “healthcare
professional” and “health care professional” which resulted in 1,767,051 hits.
Combining the three searches and applying the limits of English language, systematic
reviews, meta-analysis and randomized controlled trial resulted in 163 hits, of which 7
articles met the inclusion criteria. Controlled vocabulary was not used in this search.
The search of these databases resulted in the inclusion of 23 articles for
evaluation and critical appraisal. A review of the 23 articles revealed one article was
a repeat, two articles only addressed PPD screening in the two to three days after birth
and two articles did not assess postpartum women at well-child visits. Ultimately 17
articles were included in this review.
In addition, a search for clinical practice guidelines and recommendations
from relevant professional organizations was also conducted. The U.S. Preventive
Services Task Force (USPSTF) updated its recommendations for screening for
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depression in January 2016. The current recommendation is to screen for depression
in the general adult population, including pregnant and postpartum women. This
recommendation applies to adults 18 years and older with implementation when
systems are in place to ensure adequate follow-up (Siu, 2016). The American
Academy of Family Physicians, the American College of Obstetricians and
Gynecologists, and the American Academy of Pediatrics have issued position
statements which address screening mothers for postpartum depression. The
American Academy of Family Physicians recommends screening for depression in the
general adult population, as well as pregnant and postpartum women. The American
College of Obstetricians and Gynecologists recommend screening patients at least
once during the perinatal period for depression and anxiety and the American
Academy of Pediatrics recommends that mothers be screened for depression at the
two week, two month, four month and six month well-child visits (Siu, 2016).
Appraisal and Synthesis of the Evidence
While the prospect of appraising evidence obtained from a search of the
literature may seem daunting, Melnyk and Fineout-Overholt (2015) describe three key
questions to guide the initial evaluation of evidence. These questions address the
validity, reliability, and applicability of the literature to the posed clinical question.
After the literature is selected, it is important to establish the level of evidence. The
rating system presented by Fineout-Overholt and Stillwell (2015) was used for this
purpose. In this method, the literature is evaluated and assigned a level as follows:
Level I; systematic review or meta-analysis of randomized control trials, Level II;
randomized control trials, Level III; control trials without randomization, Level IV;
case control and cohort studies, Level V; systematic reviews of descriptive and
qualitative studies, Level VI; descriptive or qualitative studies, and Level VII; expert
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opinion or expert committee reports. During the review of literature, no level I
systematic review, which addressed the PICOT question, was found. Two Level II
randomized control trials, two Level IV cohort studies, two Level V systematic
reviews of quantitative and qualitative studies, and 11 Level VI single descriptive or
qualitative studies were found to be relevant in answering the PICOT question.
Identification of the level of evidence is an important first step in appraisal of
the literature, however this information alone is inadequate in establishing the
potential value or harm of an intervention. Guyatt et al. (2008a) assert that
“insufficient attention to quality of evidence risks inappropriate guidelines that may
lead clinicians to act to the detriment of their patients” (p. 925). For the purpose of
evaluating the quality of the evidence and determining the strength of
recommendation for a practice change, the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) was used (Guyatt et al., 2008b).
The Grading of Recommendations Assessment, Development and Evaluation
(GRADE) working group provides clear and comprehensive methods for the
subjective rating of evidence and offers four levels of quality: high, moderate, low,
and very low. The GRADE approach considers the highest quality of evidence to be
randomized trials and the lowest quality of evidence to be observational studies. The
system identifies five factors which can decrease the quality of the evidence: study
limitations, inconsistency of results, indirectness of evidence, imprecision, and
publication bias. Three factors are identified which may increase the quality of the
evidence: large magnitude of effect, plausible confounding, and dose-response
gradient (Guyatt et al., 2008c). Although lower level evidence, such as observational
studies, may initially receive a lower rating in this system, the GRADE approach
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includes the importance for this type of evidence in determining recommendations
when the evidence has a large treatment effect (Guyatt et al., 2008c).
In addition, GRADE provides guidance in the determination of a
recommendation for a change in practice. GRADE has two categories for
recommendations: strong and weak. The strength of the recommendation is
determined by the quality of evidence, the balance between desirable and undesirable
effects, values and preferences, and costs (Guyatt et al., 2008b). For example, if the
quality of the evidence is moderate or low but the effects of the intervention are
highly desirable and risks of the intervention are minimal then a strong
recommendation may be offered.
Four themes emerged from a review of the literature related to the PICOT
question: (a) persistence of PPD beyond the immediate postpartum period, (b)
pediatric providers’ belief that it is their responsibility to assess mothers for PPD, (c)
acceptability of screening for PPD during well child visits by pediatric providers and
mothers, and (d) effectiveness of screening for PPD during well child visits.
Persistence of Postpartum Depression. In a study conducted by Chaudron,
Kitzman, Szilagyi, Sidora-Arcoleo and Anson (2006) findings show that of 67 women
assessed for PPD at well child visits 33% reported high symptom levels during the
first year, 26% developed high symptom levels after the first 3 months, and 41%
showed improvement in symptoms after three months. In an integrated review,
Liberto (2012) reports that PPD affects 10 to 15% of postpartum women. This is a
significant cause for concern since PPD is known to have adverse effects on child
development and women’s interaction with their provider ends shortly after birth.
Stowe, Hostetter and Newport (2005) report that 11.5% of women experience prenatal
onset of depressive symptoms, 22.0% experience late onset postpartum symptoms and
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66.5% experience an early onset of postpartum symptoms. Table 2 displays the
evaluation of the literature regarding the persistence of postpartum depression.
Pediatric Providers’ Beliefs. In a cross-sectional survey of United States
primary care pediatricians, Olson et al. (2002) report that 54% of providers believe it
is their responsibility to recognize PPD in mothers. These providers also identified
lack of time and training in screening for PPD as barriers. Leiferman, Dauber, Heisler
and Paulson (2008) surveyed obstetricians, pediatricians and family medicine
practitioners. All specialty providers believed that it was their responsibility to screen
for PPD. Among this group of providers, pediatricians reported being the least
comfortable with screening and discussing PPD. In a study by Heneghan, Morton and
DeLeone (2007) all pediatricians believed that it was appropriate to ask mothers about
their health during well-child visits. These providers reported that they relied on
observational cues to identify PPD, rarely used screening tools, and noted time as a
barrier in identifying PPD. Goldsmith (2007) explored PPD screening behaviors of
family nurse practitioners and found that of those who saw postpartum women 42%
never screened for PPD. The single biggest predictor of screening behavior in this
group was confidence in how to use a screening tool. Mason and Poole (2008)
interviewed health care professionals who used the Edinburgh Postnatal Depression
Scale (EPDS) to screen for PPD. These providers had positive views on using this
screening tool and believed it was a useful tool in opening a dialogue about PPD.
However, they did express concern about the question regarding self-harm and its
potential to offend some mothers. Santos, Gualda, Silveira and Hall (2013) studied
the attitudes of Brazilian physicians and nurses regarding screening for PPD and
found these professionals did not believe it was their responsibility to screen for PPD
and that depression was the domain of psychiatry.
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Table 2
Persistence of Postpartum Depression
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Citation

Design/Method

Sample/Setting

Chaudron, L.H.,
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record included two
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EPDS forms

Method:
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review of data
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prior study of
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mothers who
brought their
child to well child
care visits in the
year after birth
and completed
the Edinburgh
Postnatal
Depression Scale
(EPDS)

- Data collected
from large pediatric
practice affiliated
with a university
medical center in a
large city

Outcome
Measurement
-Edinburgh Postnatal
Depression Scale
(EPDS) a 10-item,
self-administered
questionnaire
- Developed as a
screening tool (not
diagnostic) to assess
depressive symptoms
in women who have
given birth recently
- Validated in many
settings and in large
samples
- Sensitivity of 93%
and specificity of 83%
at 6 to 8 weeks
postpartum for a score
> or = 10 for major
depression
- Cutoff score of 10
was used to indicate
clinically significant
symptoms for this
study

Data Analysis

Findings

- Proportions were
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postpartum
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completed the
EPDS at least
once before 3
months and
between 3 and
11 months
postpartum,
33% were
identified with
high symptom
levels
throughout the
year, 41%
improved after
the first 3
months and
26% developed
high symptom
levels after the
first 3 months

Level of
Evidence
Level VI

Quality of
Evidence
Moderate

Citation

Design/Method

Sample/Setting

Liberto, T.L.
(2012). Screening
for depression
and help-seeking
in postpartum
women during
well-baby
pediatric visits:
An integrated
review. Journal
of Pediatric
Health Care,
26(2), 109-117.

Design:
- Integrated
review of
literature from
qualitative,
quantitative and
mixed method
research

Primary source
documents
published from
1995 to 2009

14

Method:
- Systematic
review of
literature of
English language
research
-Used Academic
Search Premier,
CINAHL,
MEDLINE,
Mental
Measurements
Yearbook,
PsycINFO,
PsycARTICLES,
and Women’s
Studies
International

Keywords
searched:
postpartum,
postpartum
depression, help
seeking, and
pediatric
setting/pediatrician
311 studies were
assessed for
eligibility. Thirtyfive studies met the
criteria.

Outcome
Measurement
-Integrated review
methodology by
Whittemore and Knafl
provides a framework
to guide the integrated
review process to
enhance the rigor of
the review

Data Analysis

Findings

- Each article was
evaluated for
issues related to
specifying the
review purpose,
searching the
literature,
evaluating data
from primary
sources, analyzing
data and
presenting results

- Postpartum
Depression
(PPD) affects
10%-15% of all
women after
birth
- Women with
PPD generally
do not seek help
for depression
- Untreated PPD
has significant
adverse effects
on maternal
bonding,
parenting and
the infant’s
development
- Womens’
interaction with
their obstetric
provider ends
shortly after
birth
- Frequent
interactions
with the
pediatric office
continue
throughout the
child’s first two
years of life.

Level of
Evidence
Level V

Quality of
Evidence
Moderate
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Citation

Design/Method

Sample/Setting

Stowe, Z.,
Hostetter, A.L.
& Newport, D.J.
(2005). The
onset of
postpartum
depression:
Implications for
clinical
screening in
obstetrical and
primary care.
American
Journal of
Obstetrics and
Gynecology,
192(2), 522-526.

Design:
- descriptive

n = 209
Women included
fulfilled criteria
for major
depression and
were not taking
psychotropic
medication

Method:
- Women
referred to a
women’s mental
health program
for evaluation of
postpartum
depression
- Descriptive
analysis was
conducted for 3
participant
groups:
pregnancy onset,
early postpartum
onset within 6
weeks of
delivery and late
postpartum onset

Outcome
Measurement
At presentation,
women completed the
Edinburgh Postnatal
Depression Scale,
Beck Depression
Inventory and an
intake questionnaire
Time of illness was
defined as the
beginning of the
current major
depressive episode

Data Analysis

Findings

-Frequency tests
for categorical
data and analysis
of variance with
post hoc TukeyKramer multiple
pairwise
comparison tests
for continuous
data

-Among
participants,
11.5% reported
prenatal onset,
22.0% late
postpartum
onset and
66.5% early
postpartum
onset
- Those
reporting
pregnancy
onset were
likely to be
unmarried and
those with late
postpartum
onset were
likely to report
a previous
history of
postpartum
depression

Level of
Evidence
Level VI

Quality of
Evidence
Moderate

Table 3 demonstrates evaluation of the literature regarding pediatric providers’ beliefs
for screening for PPD at well-child visits.
Acceptability of Screening. In a systematic review, Brealey, Hewitt, Green,
Morrell and Gilbody (2010) found that screening for PPD was acceptable to women
and healthcare providers. However, both groups reported that advance notice of
screening was preferable and there was concern over the self-harm question contained
in the EPDS. Both groups also felt it was important to discuss the results of the
screen during a visit. Gjerdingen, Crow, McGovern, Miner and Center (2009) found
women were more likely to complete PPD screening at pediatric clinics than at family
medicine clinics. In a study by Olson, Dietrich, Prazar and Hurley (2006), mothers
and healthcare providers found that screening for PPD was acceptable and that it took
less than three minutes to discuss screening results. Walker, Eun-Ok and Tyler
(2013) report that 85% of the women surveyed in their study found it acceptable to
discuss maternal health needs at pediatric visits. This rate was consistent across races
and income levels. Byatt, Biebel, Friedman, Debordes-Jackson and Ziedonis (2013)
identified barriers and facilitators for women being screened for PPD in the pediatric
setting. Barriers included fear of stigma and loss of parental rights with a positive
screen and ambivalence about pediatric providers conducting the screening.
Facilitators included appreciation of addressing the medical and mental health needs
of mother and baby and that this approach to screening was de-stigmatizing since it
was universal. Table 4 displays the evaluation of the literature regarding the
acceptability of screening for PPD by mothers.
Effectiveness of Screening. In a study comparing automated screening to
reminders to screen for PPD during well-child checks, Carroll, Biondich, Anand,
Dugan and Downs (2013) demonstrated that automated screening resulted in
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Table 3
Pediatric Providers’ Beliefs
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Citation

Design/Method

Sample/Setting

Olson, A.L.,
Kemper, K.J.,
Kelleher, K.J.,
Hammond, C.S.,
Zuckerman, B.S.
& Dietrich, A.J.
(2002). Primary
care
pediatricians’
roles and
perceived
responsibilities
in the
identification and
management of
maternal
depression.
Pediatrics,
110(6), 11691176.

Design:
- descriptive (crosssectional survey)

n = 508
Primary care
pediatricians
randomly
selected from the
American
Academy of
Pediatrics
member list
(excluding
resident,
emeritus and
subspecialty
members)

Method:
- National survey of
randomly selected
primary care
pediatricians

Outcome
Measurement
45-item
questionnaire
adapted for
pediatricians from
an adult primary
care provider
survey of
depression
management
Questionnaire asked
about the last
recalled case of
postpartum or other
maternal
depression, barriers
to care, attitudes
about recognition
and management,
confidence in skills
and willingness to
implement new
strategies to
improve care
Development and
piloting previously
described

Data Analysis

Findings

-X2 and Fisher
exact test for
categorical
variables

-57% of
pediatricians
believed it was
their responsibility
to recognize
maternal
depression
-32% reported
discussion using
the term
depression, 40%
discussed without
the term and 28%
did not discuss at
all
- Lack of time
(73%) and
inadequate
training (64%)
were the greatest
barriers identified
-28% of
pediatricians
would consider
changing their
approach with
maternal
depression

P < .01 due to the
use of multiple
comparisons

Level of
Evidence
Level VI

Quality of
Evidence
Moderate
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Citation

Design/Method

Sample/Setting

Leiferman, J.A.,
Dauber, S.E.,
Heisler, K. &
Paulson, J.F.
(2008). Primary
care physicians’
beliefs and
practices toward
maternal
depression.
Journal of
Women’s
Health, 17(7),
1143-1150.

Design:
- descriptive

N = 217
PCPs:
obstetricians
(22.6%),
pediatricians
(37.3%) and
family medicine
practitioners
40.1%)

Method:
- PCPs
(obstetricians,
pediatricians and
family medicine
practitioners)
completed a 60item survey, by
either web or mail.

- rural, midAtlantic state in
the United
States

Outcome
Measurement
-Survey developed
in 2006 to assess
PCPs’ attitudes,
beliefs and
practices regarding
the assessment and
treatment of
maternal
depression
- Initial pool of
items was
developed based
on literature review
and physician
interviews
-Item set was
narrowed and
content validity
was assessed by a
panel of PCPs
from the relevant
specialties
-Survey was pilottested by another
group of PCPs

Data Analysis

Findings

-SPSS version
14
- Chi-square and
one-way
ANOVAs
analyses of
survey items

-Across
specialties PCPs
believed it was
their
responsibility to
recognize
maternal
depression
-Pediatricians
were least
comfortable
discussing
depression
symptoms, less
familiar with
DSM-IV criteria
for depression
and less confident
to diagnose and
treat maternal
depression (p <
.001)

Level of
Evidence
Level VI

Quality of
Evidence
Low
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Citation

Design/Method

Sample/Setting

Heneghan,
A.M., Morton,
S. & DeLeone,
N.L. (2007).
Paediatricians’
attitudes about
discussing
maternal
depression
during a
paediatric
primary care
visit. Child:
Care, Health and
Development,
33(3), 333-339.

Design:
- qualitative

n = 23
Pediatricians
practicing in a
practice-based
research
network

Method:
- In-depth
telephone
interviews, each
lasting
approximately 30
minutes
-Question were
developed based on
similar, field-tested
questions that were
used for maternal
focus groups

- Large urban
area

Outcome
Measurement
-10 interview
questions
developed a priori
to elicit
pediatricians’
perceptions and
attitudes about
discussing
maternal
depressive
symptoms in the
context of a
pediatric primary
care visit

Data Analysis

Findings

- Researcher
experienced in
coding an
analyzing
qualitative data
oversaw all data
analyses.
- Immersion and
crystallization
techniques
- Codebook was
created and
responses were
coded in a
question-byquestion order,
including noted
non-verbal
responses
-All study
investigators
reviewed and
coded transcripts

-All pediatricians
agreed it is
appropriate to ask
mothers about
their health
during well-child
visits
- Pediatricians
rely on
observational
cues, especially
mother-child
interactions
- Few used direct
questions or a
checklist
- Lack of time
was the greatest
barrier identified
- One-third of
pediatricians
expressed the fear
of judgment and
stigma that a
mother may face
when discussing
maternal stresses

Level of
Evidence
Level VI

Quality of
Evidence
Moderate

Citation

Design/Method

Sample/Setting

Goldsmith, M.E.
(2007).
Postpartum
depression
screening by
family nurse
practitioners.
Journal of the
American
Academy of
Nurse
Practitioners,
19(6), 321-327.

Design:
- Descriptive,
nonexperimental
survey design

N = 159
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Method:
- Self-report data
collected via a
questionnaire
mailed to family
nurse practitioners
(FNPs) who were
members of the
American Academy
of Nurse
Practitioners
(AANP) residing in
Illinois or
Wisconsin

- FNPs were
chosen as the
focus of the
investigation
because they are
most likely to
encounter
postpartum
women in a
variety of
settings:
pediatrics,
women’s health
or internal
medicine

Outcome
Measurement
-Questionnaire for
the study was
developed by the
author
- 15 questions, 4
pages and
approximately 10
minutes to
complete
- Used to collect
data on the
subjects’ use of
screening tools and
barriers to
screening they
encounter
-Instrument
underwent pilot
testing for clarity,
validity, and ease
and speed of use
among FNP and
physician assistant
colleagues

Data Analysis

Findings

- SPSS
- Pearson
product-moment
correlations to
determine the
relationships
between
screening
behaviors and
characteristics of
practice settings
and of the
responding FNPs

- 84% of
respondents saw
at least one
postpartum
woman yearly
- 42% never
screened for
postpartum
depression
- Subjects’
confidence in
how to use a
screening tool
was the single
best predictor of
screening
behavior (r =
.487)

Level of
Evidence
Level VI

Quality of
Evidence
Moderate

Citation

Design/Method

Sample/Setting

Mason, L. &
Poole, H.
(2008).
Healthcare
professionals’
views of
screening for
postnatal
depression.
Community
Practitioner,
81(4), 30-33.

Design:
- Qualitative
(phenomenological)

n = 19
Healthcare
professionals
who administer
the EPDS

Method:
- Private semistructured
interviews

- one primary
care Trust
(PCT) in
England

21

Outcome
Measurement
-Private, semistructured
interviews lasting
between 25-75
minutes
- Interviews were
audio recorded,
transcribed and
checked for
accuracy by
simultaneously
listening to the
tapes while reading
the transcripts

Data Analysis

Findings

-Transcripts
were
independently
read and re-read
to identify
themes and their
interrelationships
-Throughout
analysis, each
author acted as a
check on the
analytic account
of the other
author to ensure
the developing
analysis was
systematic with
results supported
by the data

-All staff were
positive about
using the EPDS,
while some felt it
was a ‘tool” to
open up
discussion
- The item asking
about self-harm
was the most
problematic for
HCPs. Many
voiced concern
that it could
offend some
mothers –
Participants also
relied on their
experience, the
mothers’ nonverbal cues and
body language
when assessing
for postnatal
depression

Level of
Evidence
Level VI

Quality of
Evidence
Moderate
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Sample/Setting

Santos, H.P.
Gualda, D.M.,
Silveira, M.D. &
Hall, W.A.
(2013).
Postpartum
depression: The
(in) experience
of Brazilian
primary
healthcare
professional.
Journal of
Advanced
Nursing, 69(6),
1248-1258.

Design:
- Qualitative
(descriptive)

n=17
Purposeful
sample of 10
nurses and 7
physicians

Method:
- open-ended
interviews

- 14 primary
health care units
in an urban area
in Northeastern
Brazil

Outcome
Measurement
-Open-ended
interview
averaging 30
minutes
- All interviews
were audio
recorded,
transcribed and
checked for
accuracy

Data Analysis

Findings

- Audio-recorded
interviews were
transcribed into
verbatim reports
- 3 of the 4
authors checked
the audiotapes
against the
transcriptions to
ensure data
accuracy
- Interviews
were coded line
by line
- Codes were
clustered into
categories which
resulted in the
development of
themes

Themes:
- Limited
professional
exposure to
postpartum
depression
- Postpartum
depression as the
domain of
psychiatry
- Few
professionals felt
postpartum
depression
merited their
attention
- Women with
postpartum
depression were
usually identified
by family
members
- Care providers
reported
inadequate time
and access to
screening
techniques

Level of
Evidence
Level VI

Quality of
Evidence
Moderate

Table 4
Acceptability of Screening
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Citation

Design/Method

Sample/Setting

Brealey, S.D.,
Hewitt, C.,
Green, J.M,
Morrell, J. &
Gilbody, S.
(2010).
Screening for
postnatal
depression-is it
acceptable to
women and
healthcare
professionals? A
systematic
review and
meta-synthesis

Design:
- Systematic review
of literature from
qualitative and
quantitative research

Articles needed
to address the
acceptability of
PND screening
during the
prenatal and
postnatal
period.

Method:
- Systematic review
of research literature
without language or
geographical
restrictions
-Used MEDLINE,
CINAHL,
PsychINFO,
EMBASE,
CENTRAL, DARE,
CDSR, SSCI,
Maternity and Infant
Care, NRR, ReFeR,
mRCT, HSRProj,
LILACS, Inside
Conferences and
Dissertation Abstracts
-All databases were
searched from their
inception until
February 2007

225 studies
were assessed
for eligibility.
Sixteen studies
met the criteria.

Outcome
Measurement
-Edinburgh
Postnatal
Depression Scale
(EPDS)-the focus of
15 studies
- Beck Depression
Inventory
- Diagnostic
Interview Schedule
- Faces
- General Health
Questionnaire-30
- Postnatal
Depression
Screening Scale
- Pregnancy
Questionnaire

Data Analysis

Findings

- 2 independent
reviewers
independently
assessed the titles
and/or abstracts of
the citations from
the electronic
searches
- The 2 reviewers
independently
performed the
extraction of data
for a sample of
studies each and
one of the
reviewers checked
all studies

- women liked to
be informed in
advance about the
questionnaire
- healthcare
providers agreed
with mothers about
prior notification
- women preferred
to talk when
completing the
questionnaire and
wanted feedback
on the results
- healthcare
providers also
found it useful to
discuss results
- the question
about self-harm on
the EPDS
concerned both
groups

Level of
Evidence
Level V

Quality of
Evidence
Low
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Citation

Design/Method

Sample/Setting

Gjerdingen, D.,
Crow, S.,
McGovern, P.,
Miner, M. &
Center, B.
(2009).
Postpartum
depression
screening at
well-child visits:
Validity of a 2question screen
and the PHQ-9.
Annals of
Family
Medicine, 7(1),
63-70.

Design:
- Descriptive

n = 506
Subjects
represented
approximately
33% of the
estimated
eligible
women
(English
literate, 12
years of age or
older and have
a 0 to 1month-old
infant

Method:
- Mothers were
asked to complete
questionnaires
during well-child
visits at 0 to 1, 2, 4,
6 and 9 months
postpartum
-Each questionnaire
included 2
depression screen:
the 2-question screen
and the PHQ-9
-Mothers also
initially completed
the depression
component of the
Structured Clinical
Interview for DSMIV (SCID) and again
if either screening
result was positive
for depression

- 7 large
clinics from a
large
metropolitan
area (4 family
medicine
residency
clinics and 3
pediatric
private clinics

Outcome
Measurement
-2-question screen
(diminished mood
and pleasure)
- PHQ-9 (contains
the DSM-IV criteria
for major
depressive
disorder)
- depression
component of
SCID

Data Analysis

Findings

- 2-question
screen results
were reported as
positive if the
respondent
answered “yes”
to either or both
of the questions
- Highest
sensitivity
(100%) was seen
with the 2question screen
- Highest
specificity (94%)
was seen with the
PHQ-9

-Results suggest
the value of a 2stage procedure
for screening for
PPD
- 2-question
screen that is
positive for
depression is
followed by a
PHQ-9
- Women enrolled
from pediatric
clinics were more
likely to complete
their
questionnaires
than those
enrolled from
family medicine
clinics (46.3% vs
27.2%, P = .000)

Level of
Evidence
Level VI

Quality of
Evidence
Low

Citation

Design/Method

Sample/Setting

Olson, A.L.,
Dietrich, A.J.,
Prazar, G. &
Hurley, J.
(2006). Brief
maternal
depression
screening at
well-child visits.
Pediatrics,
118(1), 207-216.

Design:
- cohort study

Sample:
- n=1,398
Mothers
screened at
well-child
visits

Method:
- implementation of
brief depression
screening of mothers
at well-child visits
for children of all
ages for 1 month and
then implemented
again for 6 months

Setting:
- rural
pediatric
practices
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Outcome
Measurement
-Patient Health
Questionnaire
(PHQ)-2
-asks the 2 USPTFendorsed questions
regarding a) altered
mood and
anhedonia in the
past two weeks
PHQ-2 is derived
from the 9-item
Patient Health
Questionnaire
(PHQ-9)
- PHQ-2 has been
validated in both
primary obstetric
care and shown to
perform as well as
longer screening
measures
- It has a sensitivity
for major
depression of 83%,
a specificity of
92% and a positive
likelihood ratio of
2.9

Data Analysis

Findings

- x2 and Fisher’s
exact test for
categorical
variables
-t test and
Pearson’s
correlation

- Screening rates
during the initial
1-month trial were
74%
- Screening rates
during the 6
month trial were
67%
-62.4% of
providers
discussed,
referred and
followed-up by
phone when
mothers were
identified with
depressive
symptoms
-83.5% of
mothers who
screened positive
for depression
were willing to
take action
-discussion of
screening results
required less than
3 minutes
(P<.001)

Level of
Evidence
Level IV

Quality of
Evidence
Moderate
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Citation

Design/Method

Sample/Setting

Walker, L.O.,
Eun-Ok, I. &
Tyler, D.O.
(2013). Maternal
health needs and
interest in
screening for
depression and
health behaviors
during pediatric
visits. Journal of
Pediatric Health
Care, 27(4),
267-277.

Design:
- descriptive (crosssectional survey)

n = 145
Sample
balanced for
race/ethnicity
and income
level

Method:
- mail survey with
names randomly
drawn from birth
files

35.9% were of
lower income
(Medicaid
coverage) and
64.1% were of
higher income
(private
insurance)
46.2%
White/Anglo
25.5% African
American
28.3%
Hispanic
Mid size
community in
the southwest
United States

Outcome
Measurement
Survey
questionnaire
developed for this
survey was based
on the work of
Kahn et al.

Data Analysis

Findings

-X2 for
categorical
variables

-Almost two in
five women
experienced
barriers to health
care
- 22% screened
positive for
depression and
30% screened
positive for
alcohol abuse
-Acceptability of
discussing topics
(depression,
smoking and
alcohol) at
pediatric care
visits was greater
than 85%

Level of
Evidence
Level VI

Quality of
Evidence
Moderate
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Citation

Design/Method
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Byatt, N. Biebel,
K., Friedman,
L., DebordesJackson, G. &
Ziedonis, D.
(2013).
Women’s
perspectives on
postpartum
depression
screening in
pediatric
settings: A
preliminary
study. Archives
of Women’s
Mental Health,
15(5), 429-432.

Design:
- Qualitative
(grounded theory)

n=27
Purposeful
sample of
women 3-36
months
postpartum

Method:
- Focus groups (3) of
women who selfreported anxiety,
depression in
pregnancy or the
postpartum period

- Recruited
through a midsize
community
organization
that provides
education and
advocacy for
perinatal
women

Outcome
Measurement
-Focus groups
lasted
approximately 90
minutes
- All focus groups
were audio
recorded,
transcribed and
checked for
accuracy

Data Analysis

Findings

- Nvivo software
was used for
analysis
- Iterative,
constantcomparative
process was used
to review,
segment and
code data for
emerging themes
and recurrent
patterns
- Codes were
added until no
new themes
emerged
- Co-investigator
and research
coordinator had
>90% rate of
agreement

Barriers:
- Ambivalence
about screening
due to concerns
about stigma and
losing parental
rights
- Ambivalence
about the role of
pediatric health
providers
screening
- Pediatric
providers not
trained to screen
or discuss PPD
Facilitators:
- Addressing both
medical and
mental health
needs of mother
and baby
- Therapeutic, destigmatizing
approach to
screening

Level of
Evidence
Level VI

Quality of
Evidence
High

statistically significant higher rates of diagnosing maternal depression and referrals
for treatment. Leung, et al. (2011) evaluated the use of the EPDS at maternal child
centers which revealed that women screened for PPD had better mental health
outcomes at six months postpartum. A study by Yawn, et al. (2012) implemented a
family medicine practice-based training program for screening, diagnosis and
management of depression in postpartum women. Participants in the intervention
group had higher rates of PPD identified as well as higher rates of treatment. These
women also had lower levels of depressive symptoms levels at six and 12 months
postpartum. Chaudron, Szilagyi, Kitzman, Wadkins and Conwell studied the effects
of universal screening for PPD using the EPDS at well-child visits during the first
year of life. Results of this study showed a statistically significant increase in
detecting PPD in a pediatric practice. Table 5 displays the evaluation of the literature
regarding the effectiveness of screening for PPD by pediatric providers.
Screening Tools. Findings in the literature established that multiple tools are
available and used to screen for PPD. However, not all of the tools are designed to
screen specifically for PPD. The Patient Health Questionnaire-9 (PHQ-9) is a nineitem questionnaire that is completed by the patient. It takes five to ten minutes to
complete and can be scored by the patient or staff (National Institute for Healthcare
Management, 2010). The PHQ-9 has been demonstrated as a reliable and valid
measure of depression severity in adults (Kroenke, Spitzer & Williams, 2001). The
Patient-Health questionnaire-2 (PHQ-2) consists of the first two questions from the
PHQ-9 and assesses for depressed mood and anhedonia. It takes less than one minute
to complete and if positive is not considered diagnostic, but indicates the need for
further evaluation (Kroenke, Spitzer & Williams, 2003). The Beck Depression
Inventory (BDI) is a 21-item, self-report rating inventory that assesses for the
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Table 5
Effectiveness of Screening
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Citation

Design/Method
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Carroll, A.E.,
Biondich, P.
Anand, V.,
Dugan, T.M. &
Downs, S.M.
(2013). A
randomized
control trial of
screening for
maternal
depression with a
clinical decision
support system.
Journal of the
American
Medical
Informatics
Association,
20(2), 311-316.

Design:
- non-blinded,
interventional,
randomized control
trial
Method:
- computer program
assigned randomized
families into
intervention and control
groups
- one intervention
group received
screening questions for
mothers and providers
were alerted to positive
screens
- one intervention
group received
screening questions and
providers were alerted
to positive screens and
were provided with
materials to share with
mothers
- in the control group
providers were
reminded to screen

Sample:
- intervention
group receiving
screening
questions, n=1167
- intervention
group receiving
screening
questions and
materials, n=1167
-control group,
n=1186
Setting:
- Academic
pediatric clinic

Outcome
Measurement
-CHICA
Prescreening form
with maternal
depression
questions
- The Child Health
Improvement
through Computer
Automation
(CHICA) system is
a decision support
and electronic
medical record
system used in the
study setting

Data
Analysis
- x2 to test for
differences
between
groups after
randomization

Findings
- Diagnosis of
maternal depression
and referral for
assistance occurred
significantly more
often in both the
screening (2.4%)
and the screening
and materials group
(2.4%) than in the
control group
(1.2%)
- OR 2.06 (95% CI
1.08 to 3.93)

Level of
Evidence
Level II

Quality of
Evidence
Moderate
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Leung, S.L.,
Leung, C., Lam,
T.H., Hung,
S.F., Chan, R.,
Yeung, T.,
Miao, M,
Cheng, S.,
Leung, S.H.,
Lau, A. & Lee,
D.T. (2010).
Outcome of a
postnatal
depression
screening
programme
using the
Edinburgh
Postnatal
Depression
Scale: A
randomized
control trial.
Journal of
Public Health,
33(2), 292-301.

Design:
- randomized control
trial
Method:
- simple
randomization
generated by a
research officer not
involved in the rest of
the study
- participants in the
intervention group
were screened for
PND using the EPDS
- control group
screened by clinical
assessment

Sample:
- Mothers with 2
month old babies,
n=462

Outcome
Measurement
-Edinburgh
Postnatal
Depression Scale
(EPDS)

Setting:
- Maternal and
child health
centers in Hong
Kong

- The EPDS has
been established as
a valid and reliable
screening tool for
PND

Data
Analysis
- SPSS
version 14
- Binary
measure
between
intervention
and control
groups
analyzed and
presented as
risk ration
(RR) and
95%
confidence
interval (CI)

Findings
- The intervention
group had better
maternal mental
health outcome at
6 months postnatal
(RR 0.59, 95% CI
0.39-0.89)

Level of
Evidence
Level II

Quality of
Evidence
Moderate
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Citation

Design/Method

Sample/Setting

Yawn, B.P.,
Dietrich, A.J.,
Wollan, P.,
Bertram, S.,
Graham, D.,
Huff, J.,
Kurland, M.,
Madison, S. &
Pace, W.D.
(2012).
TRIPPD: A
practice-based
network
effectiveness
study of
postpartum
depression and
management.
Annals of
Family
Medicine, 10(4),
320-329.

Design:
- randomized control
trial
Method:
- randomization was
done by practice as the
intervention involved
changes in care at the
practice level
- intervention and
usual care were not
provided within the
same practice

Sample:
- 28 practices
randomized to
usual care (n=14)
or intervention
(n-14)
-2,343 women
were enrolled
between 5 and 12
weeks’
postpartum
- 1,897 (80.1%)
provided
outcome
information and
were included in
the analysis
Setting:
- family medicine
research network
practices

Outcome
Measurement
-Edinburgh
Postnatal
Depression Scale
(EPDS)
- 9-item Patient
Health
Questionnaire
(PHQ-9)
- A woman was
classified as
receiving the
intervention if the
clinic offered the
intervention at the
time of her
enrollment
- Primary outcome
was a 5-point or
greater drop in
PHQ-9 score from
baseline to 6 or 12
months’
postpartum

Data
Analysis
- S-PLUS
statistics
package
(TIBCO
Software,
Inc.)
- Generalized
linear mixed
effect models
with a
random mean
term for the
clinic

Findings
- 654 (34.5% of
1,897) women had
elevated screening
scores with
comparable rates
in the intervention
and usual-care
groups
- Those in the
intervention
practices were
more likely to
receive a diagnosis
(P=.0006) and
therapy for
postpartum
depression
(P=.002). This
group also had
lower depressive
symptom levels at
6 (P=.07) and 12
months’ (P=.001)

Level of
Evidence
Level II

Quality of
Evidence
Moderate
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Citation

Design/Method

Sample/Setting

Chaudron, L.H.,
Szilagyi, P.G.,
Kitzman, H.,
Wadkins, H.I. &
Conwell, Y.
(2004).
Detection of
postpartum
depressive
symptoms by
screening at
well-child visits.
Pediatrics,
113(3), 551-558.

Design:
- cohort study

Sample:
- n=110
Cohort #1:
randomly
selected 110
infant medical
records before
screening was
initiated
-n=110
Cohort #2:
randomly
selected 110
infant medical
records after
screening was
initiated

Method:
- implementation of
universal screening for
postpartum depressive
symptoms during first
year well-child visits
using the Edinburgh
Postnatal Depression
Scale (EPDS).

Setting:
- large pediatric
primary care
practice affiliated
with a medical
center in a large
city

Outcome
Measurement
-Edinburgh
Postnatal
Depression Scale
(EPDS)
- The EPDS has
been established as
a valid and reliable
screening tool for
PND

Data
Analysis
- x2 and
Fisher’s
exact test for
detection and
referrals
- post hoc
analyses
using x2 and
Fisher’s
exact tests to
compare
detection at
well-child
visits in
cohort 1 and
well-child
visits in
cohort 2

Findings
- 46% of visits in
cohort 2 included
an EPDS form in
the medical record
- among women
who completed the
EPDS, 27% (n=16)
had high
depressive
symptoms at some
time during the
first year
- statistically
significant increase
in detection from
cohort #1 (1.6%)
to cohort #2
(8.5%) P<.001 and
in referral (0.2%)
to (3.6%) P<.005

Level of
Evidence
Level IV

Quality of
Evidence
Moderate

attitudes and symptoms of depression and takes approximately 10 minutes to complete
(American Psychological Association, 2015). The BDI has been criticized as it primarily
focuses on the somatic symptoms of depression which can often overlap with symptoms
experienced during the postpartum period (Boyd, Le, & Somberg, 2005).
The Postpartum Depression Screening Scale (PDSS) is a 35-item tool that assesses
seven dimensions: (a) sleeping and eating disturbances, (b) anxiety and insecurity, (c)
emotional lability, (d) cognitive impairment, (e) loss of self, (f) guilt and shame, and (g)
thoughts of self- harm. This tool takes five to 10 minutes to complete (Beck & Gable, 2000).
The Edinburgh Postnatal Depression Scale (EPDS) is the tool most commonly used to assess
for depression in the postpartum period. This 10-item questionnaire, takes less than 5
minutes to complete and assesses the emotional and cognitive symptoms of PPD with one
question to measure sleep disturbances (Boyd, Le, & Somberg, 2005). The EPDS has been
the most researched tool used to measure PPD. Table 6 provides a comparison of screening
tools considered for this project.
Implications for Practice
The synthesis of evidence from this review indicated that there is a need for early
identification of PPD as it has serious negative effects on maternal well-being and infant
development (Liberto, 2012). The quality and grade of the evidence also indicated that there
are valid screening tools for PPD, screening is acceptable to mothers and pediatric providers
and screening at well-child visits can successfully identify mothers at risk for PPD
(Chaudron, Szilyagyi, Kitzman, Wadkins and Cornwell, 2004). A synthesis table outlining
the important elements included in this review is provided in Table 7.
Recommendation for Practice Change
Based on the level, quality and strength of the evidence, the recommendation was to
screen postpartum mothers for PPD using the EPDS at well-child visits during the first year
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Table 6
Postpartum depression screening tools comparison
Tool
Length
Time period
Developed
of use
for assessment for use in
postpartum
women

Cost for
use

Sensitivity and
specificity

Patient Health
Questionnaire-9
(PHQ-9)

9 items

Adults at any
time

No

Free

88% sensitivity
88% specificity

Patient Health
Questionnaire-2
(PHQ-2)

2 items

Adults at any
time

No

Free

83% sensitivity
92% specificity

Beck Depression
Inventory (BDI)

21 items

Adults at any
time

No

$105
(manual and
50 forms)

47.6-82%
sensitivity
85.9-89%
specificity

Postpartum
Depression
Screening Scale
(PDSS)

35 items

Postpartum

Yes

$79.75
(manual and
25 forms)

91-94%
sensitivity
72-98%
specificity

Edinburgh
Postnatal
Depression
Screening Scale
(EPDS)

10 items

Prenatal and
postpartum

Yes

Free

59-100%
sensitivity
49-100%
specificity

(American Psychological Association, 2015; Beck & Gable, 2000; Boyd, Le, & Somberg,
2005; Kroenke, Spitzer & Willliams, 2001; National Institute for Healthcare Management,
2010)

of life and to provide resources and referrals as indicated.
The EPDS is the most commonly used and validated tool used to screen for PPD and
was chosen to use for this project (Appendix A). The EPDS is free to use for screening
purposes as long as it is used in its entirety and copyright laws are followed by always
including the names of the authors and the title of the article and journal in which it first
appeared (Cox, Holden & Sagovsky, 1987). The screening tool contains 10 questions
including one on suicidal ideation and is completed by the patient and is easily and quickly
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Table 7
Synthesis Table
Study
Year
Author

35

Chaudron et
al
Liberto
Stowe and
Hostetter
Olson et al
Leiferman et
al
Heneghan et
al
Goldsmith
Mason and
Poole
Santos et al
Brealey et al

Persistence
of PPD

2006

+

Pediatric
Providers’
Beliefs
≠

Acceptability Effectiveness
of Screening of Screening

Screening
Tool Used

Sample Size

Level of
Evidence

Quality of
Evidence

≠

≠

EPDS

67

VI

Moderate

2012
2005

+
+

≠
≠

≠
≠

≠
≠

2002
2008

≠
≠

Δ
Δ

≠
≠

≠
≠

≠
EPDS and
BDI
≠
≠

311
209

V
VI

Moderate
Moderate

508
17

VI
VI

Moderate
Low

2007

≠

Δ

≠

≠

≠

23

VI

Moderate

2007
2008

≠
≠

Δ
Δ

≠
≠

≠
≠

≠
EPDS

159
19

VI
VI

Moderate
Moderate

2013
2010

≠
≠

¢
≠

≠
¥

≠
≠

≠
EPDS and
BDI
PHQ-2

17
16

VI
V

Moderate
Low

Gjerdingen
2009
≠
≠
¥
≠
506
VI
Low
et al
Olson et al
2006
≠
≠
¥
≠
PHQ-2
1,398
IV
Moderate
Walker et al 2013
≠
≠
¥
≠
≠
145
VI
Moderate
Byatt et al
2013
≠
≠
¥
≠
≠
27
VI
High
Carroll et al
2013
≠
≠
≠
©
CHICA
1167
II
Moderate
Leung et al
2010
≠
≠
≠
©
EPDS
462
II
Moderate
Chaudron et 2004
≠
≠
≠
©
110
IV
Moderate
al
Notes: Edinburgh Postnatal Depression Scale (EPDS), Beck Depression Inventory (BDI), Patient Health Questionnaire-2 (PHQ-2), The Child Health
Improvement through Computer Automation (CHICA), +-positive for PPD, ≠-not applicable, Δ-responsible for screening, ¢-not responsible for screening, ¥acceptability of screening, ©-effectiveness of screening

scored by office staff and reviewed by providers. The EPDS has a maximum score of
30 with a score of 10 or greater indicating possible depression. Question 10, which
assesses suicidal thoughts, should always be reviewed separately (Hirst & Moutier,
2010).
The recommendation for a practice change and the strength and rationale for
the recommendation are shown in Table 8.
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Table 8
Recommendation for Practice Change
Recommendation
Strength of Evidence for
Recommendation
1. Implement a program to screen Strong
postpartum mothers for
Postpartum Depression (PPD) in
pediatric clinics using the EPDS

Rationale
Demonstrates increase in
identification of Postpartum
Depression (PPD) in the pediatric
setting with formal screening

References in Support of
Recommendation
Carroll, A.E., et al. (2013);
Chaudron, L.H., et al. (2004);
Stowe, Z., et al. (2005);
Chaudron, L.H., et al. (2006)

Identified persistence of PPD
throughout the 12 months after
delivery
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2. Implement PPD screenings at
the 2 week, 2 month, 4 month, 6
month, 9 month, and 12 month
visit

Strong

Universal screening for PPD at wellchild visits during the first year of life
showed statistically significant
increase in detecting PPD
Mothers more likely to complete PPD
screening at pediatric clinics than at
family medicine clinics
Women’s interaction with their
provider ends shortly after birth and
there is frequent interaction with
pediatric providers throughout a
child’s first year of life

Chaudron, L.H., et al. (2004);
Gjerdingen, D., et
al. (2009);
Liberto, T.L. (2012)
Siu, A.L. (2016)

Recommendation
3. Provide training on
implementation of the screenings
to clinic staff

Strength of Evidence for
Recommendation
Strong

Rationale
Training in the use of a screening tool
increased identification of PPD
Screening for PPD during well-child
visits did not take significantly more
time
Pediatric providers believe it is their
responsibility to recognize PPD but
cite lack of training

References in Support of
Recommendation
Yawn, B.P., et al. (2012);
Olson, A.L., et al. (2006);
Olson, A.L., et al. (2002);
Leifernean, J.A., et al. (2008);
Heneghan, A.M. et al. (2007);
Mason, L., et al. (2008);
Goldsmith, M.E. (2007);
Santos, H.P., et al. (2013)
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Pediatric providers cited lack of
confidence in how to use a screening
tool was the greatest barrier to
screening
4. Discuss screening results with
mothers and provide referrals to
community resources

Strong

Mothers screened for PPD at wellchild visits had improved mental
health outcomes at 6 months
postpartum
Demonstrated that screening for PPD
at well-child visits is acceptable to
women and healthcare providers
Mothers found it acceptable to
discuss maternal health needs at
pediatric visits

Leung, S.L., et al. (2010);
Brealey, S.D., et al. (2010);
Olson, A.L., et al. (2006);
Walker, L.L., et al. (2013);
Byatt, N., et al. (2013)
Siu, A.L. (2016)

III. IMPLEMENTATION
Setting and Population
The setting for this project was a private pediatric practice in the Midwest that
is located in a small town in a rural community. The practice sees children from birth
to age 18 with a total patient population of approximately 14,000. There are eight
providers including three physicians and five pediatric nurse practitioners. Support
staff includes seven licensed practical nurses, two receptionists, a billing manager and
an office manager.
The population of interest included neonates, infants and mothers who
presented for well-child visits at the following scheduled intervals: two weeks, two
months, four months, six months, nine months, and 12 months of age. In 2015, the
pediatric practice for the project saw 1,660 infants, age two weeks to one year, for
well-child visits. Therefore, this would result in an average of 415 potential subjects
over the three-month proposed project period. Stakeholders identified for this project
were postpartum mothers and their neonates and infants, pediatric providers, clinic,
administration and payers.
Evidence-Based Practice Improvement Project Approval
The project was designed to not place the participants at risk with privacy
concerns addressed by de-identification of all protected health information (PHI)
aimed at upholding HIPAA compliance. Agency permission to complete the EBPI
project was obtained from the private pediatric clinic (Appendix B). The project
proposal was submitted to Dayton Children’s Institutional Review Board and was
determined to qualify as a non- research, quality improvement project with permission
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to proceed granted (Appendix C).
Aim Statement
Within three months of initiation of the project, providers will screen mothers
for PPD, using the EPDS, during their infant’s well-child visit greater than or equal to
80 percent of the time. Mothers who present with their children for well-child visits
will be identified and the number who receive screening and receive information and
referral will be measured. The total number of mothers eligible for screening will be
compared to the actual number of mothers who receive screening. This is a process
measurement and will demonstrate if the appropriate steps to benefit patients are
performing as planned (National Quality Forum, 2016). The aim to achieve an 80%
rate of screening was determined through conversations between the DNP student and
the office manager and providers. Since screening for PPD was not currently
practiced, an 80% screening rate over three months seemed to be a reasonable and
attainable goal for initial implementation.
Implementation Plan
Several employees at the clinic, along with the DNP student, were involved in
the implementation of the project. The team was responsible for providing education
on use of the screening tool, developing documentation within the electronic medical
record (EMR), completing screening, and providing resources and referrals when
indicated. The team members are listed in Table 9.
The DNP student served as the project leader and developed an educational
module for providers and staff regarding the project, submitted the IRB application,
served as a resource during implementation of the project, and completed data
collection and analysis. The office manager of the clinic arranged time for providers
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and staff to participate in the educational training and worked closely with the DNP
Table 9
Project Implementation Team
Role
Duties
DNP Student/Project
Leader
Office Manager
Pediatric Nurse
Practitioner
Pediatric Nurse
Practitioners
Pediatricians
Charge Nurse

Statistician

Agency

Design and implement
project
Provide education to staff
Assist with data collection
Create documentation of
screening within the EMR
Implement screening
Implement screening
Implement screening
Provide leadership to staff
nurses and receptionists in
distributing screening tool
at appropriate visits
Data analysis

Wright State University

Child and Adolescent
Specialty Care
Child and Adolescent
Specialty Care
Child and Adolescent
Specialty Care
Child and Adolescent
Specialty Care
Child and Adolescent
Specialty Care

Wright State University

student to ensure a smooth implementation of the project. A pediatric nurse
practitioner with specialized training on the EMR developed documentation of the
screening within the appropriate patient encounter templates. Another pediatric nurse
practitioner worked closely with the DNP student and provided information about
issues regarding project implementation while the DNP student was not available in
the office. The charge nurse maintained close communication with staff nurses and
receptionists and assisted in identifying appropriate visits for screening and assuring
that screening tools were provided to eligible mothers. In addition, a statistician
provided statistical support to the DNP student after data collection was completed
and the project was concluded.
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Staff Education. Prior to implementation of the project, staff and providers
received education on the principles of EBP, the prevalence and risks of PPD for
mothers and children, and training on the use of the EPDS to screen for depression.
Education included a PowerPoint presentation (Appendix D) as the addition of a
visual component has been shown to increase the retention of information by 24%
(Simmons & DiStasi, 2008). Training on use of the EPDS occurred in groups of four
or less and included education about the tool, instructions on tool completion and
scoring, and practice completing and scoring the tool. The inclusion of the active
learning techniques of hearing the information, seeing the information, and interacting
with the actual tool was utilized as combining these techniques leads to information
retention rates as high as 97% (Simmons & DiStasi, 2008). Appendix (E) shows the
teaching plan for staff and provider education.
Screening Process. The steps for the screening process were as follows:
1. The mother was provided with an information letter (Appendix F) and the
EPDS when she and her infant were brought to the exam room by the licensed
practical nurse (LPN). After the third PDSA cycle, mothers were provided this
information at check-in.
2. While waiting for the provider, the mother completed the EPDS and placed
the completed scale on the exam table. If the mother did not complete the EPDS there
were no further prompts to participate in the screening process. However, general
questions regarding the mother’s well-being were asked as this was the usual practice
of the providers in the office.
3. During the well-child visit the provider scored the EPDS. The completion
of the EPDS and score were recorded in the EMR.
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4. The provider discussed the EPDS score with the mother. If the EPDS score
was less than 10 there was no further intervention. If the EPDS score was 10 or
greater, the mother was referred to her primary care provider for further evaluation
and treatment. The mother was provided a brochure from Postpartum Support
International (Appendix G) and Many Shades of Blue (Appendix H). If question
number 10 of the EPDS was positive, the mother and infant were not left alone and
emergency services were contacted if indicated. Documentation for each of these
encounters was made in the EMR. Providers were given a decision-making algorithm
(Appendix I) which outlined the steps to take based on the EPDS score. Algorithms
were posted in each provider’s office and on the bulletin board in the hallway for ease
of use.
Melnyk and Fineout-Overholt (2015) assert that for a change to evidencebased practice to happen a strategic plan with clearly established goals must be
developed. Table 10 outlines the timeline for implementation of the project.
Outcome Measures
Screening for PPD was not conducted in the pediatric practice before the
implementation of this project. An area to record a completed screening was added to
the EMR. The number of completed screenings was measured by a review of the
EMR after implementation of the project. For this project, the number of mothers
who brought their infant in for a well-child visit and the number of mothers who were
actually screened for PPD using the EPDS was measured. In addition, another area
was added to the EMR for the provider to record the distribution of resource packets
and referrals given to mothers.
Increasing PPD screening assisted in identifying mothers with this condition
who were then provided resources and referred to their primary care provider for
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Table 10
EBP Project Implementation Timeline
Step 1: Describe the Problem
• Mothers not screened for PPD during the first year of
infant’s life
• Identify key stakeholders
• Identify facilitators and barriers and develop strategies
for addressing
Step 2: Formulate Focused Clinical Question
• Development of PICOT question
Step 3: Search for Evidence
• Identify keywords identified in PICOT question
• Conduct literature search
Step 4: Appraise and Synthesize Evidence
• Utilize Rapid Critical Appraisal method
• Identify level of evidence
• Grade evidence
• Evaluate and select appropriate screening tool for PPD
Step 5: Develop Aim (goal) Statement
• Develop Aim Statement for project
• Defend proposal
• IRB application
Step 6: Plan-Do-Study-Act cycles
• Develop and present education module for screening for
PPD
• Implement small tests of change
• Implement project with changes identified after rapid
PDSA cycles
• Data analysis
Step 7: Dissemination of Best Practices
• Final defense of project

January 2014
September 2016
September 2016

February 2014
February 2014

March 2014
March 2014
September 2015
November 2015
October 2016
October 2016
January 2017
February 2017
March-May 2017

November 2017

further evaluation and treatment. Resources included a brochure from Postpartum
Support International (2016) which provides information about the symptoms of PPD,
self-care tips, and phone and website information for support groups (Appendix G)
which was reproduced and distributed free of charge. A brochure from a local PPD
support group was also provided to mothers with positive screens and was provided
by the organization free of charge (Appendix H). For mothers who screened positive
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for PPD, providing information, resources, and referral to their primary care provider
may improve the health outcomes of mothers, infants, and families.
In addition, early identification and treatment of PPD has the potential to
reduce health care costs. Depression, especially when identified early, is highly
treatable. Early interventions have the potential to reduce negative outcomes for both
mother and infant, thus reducing the significant financial burden of depression
(National Institute of Health Care Management, 2010).
Facilitators and Barriers
Considering facilitators and barriers is a necessary step when considering any
change. As Melnyk and Fineout-Overholt (2015) assert, “change, even when
welcome, is stressful to everyone” (p. 206).
The office manager of the practice was a primary facilitator during the
development and implementation of the project. The project leader maintained this
support through frequent conversations with the office manager in person, by phone,
and through email. Through these discussions, the project leader provided evidence
of the value of the project to the practice and its patients, worked to develop an
explicit timeline of the project activities, acquired resources to be provided to
mothers, and assured the manager that the time to complete the project would not
interfere with contracted clinical hours.
Two pediatricians and two nurse practitioners also served as facilitators for the
project. One pediatrician, a co-owner of the practice, was committed to implementing
new evidence-based practices. The other pediatrician, who recently completed
residency training, was familiar with PPD screening and was encouraging to others in
the practice regarding the importance of screening mothers for PPD. One of the nurse
practitioners had acquired additional training on the EMR and was helpful in
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developing the documentation of the screening in the EMR. The other nurse
practitioner works full-time and was enthusiastic and supportive of the project from
its inception. She provided frequent feedback throughout the project and served as a
resource when the project leader was not at the office.
Unfamiliarity with the principles of EBP and lack of knowledge regarding the
EPDS screening tool were anticipated barriers to the project. Another anticipated
barrier was concern over the time needed to complete and score the screen. These
concerns were addressed during the education sessions included in the initial PDSA
cycle.
An unanticipated barrier was reluctance to implement the project by a
pediatrician and nurse practitioner. These providers were included in many
discussions regarding the development of the project and only verbalized their
hesitancy for implementation during the initial PDSA cycle. Individual conversations
were held with the providers, the office manager, and the project leader to address
their concerns. The pediatrician eventually agreed to implementation while the nurse
practitioner refused to implement the screening. The nurse practitioner subsequently
went on maternity leave during week 10 of the project and remained out of the office
for the remainder of the project.
In Table 11, facilitators and barriers for the DNP project are identified as well
as the methods utilized to address these during project implementation.
Implementation Process
Small tests of change occur during step six of the EBPI model, known as the
plan-do-study-act cycle (PDSA), (Leven, et al., 2010). To facilitate this process,
forms provided by the Institute for Healthcare Improvement (IHI) for testing change
were utilized for periodic evaluations throughout the project (Appendix J).
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Table 11
Facilitators and Barriers
Facilitators
•

Practice manager supportive of
providers

•

Pediatricians

•

Pediatric Nurse Practitioners

How Addressed in Implementation
•

Barriers

Provided evidence of value of the
project to the practice; provided
timeline of project; acquire
resources; DNP student/employee
provided time to practice outside of
obligated hours to implement project
• Solicited advice and expertise;
included in all phases of project
• Verbalized appreciation for
assistance in creating documentation
within the EMR and for serving as a
resource during the project leader’s
absence
How Addressed in Implementation

•

Unfamiliarity with EBP principles

•

•

Knowledge deficit regarding use of
screening tool
Additional time for screening

•

Providers reluctance to implement
screening

•

•

•

•

Developed and provided presentation
to providers and staff about EBP and
benefits to patient population
Provided education and practice in
use of screening tool
Implementation of screening during
patient check-in and review by
provider will not add significant time
to well-child visit
Individual conversations with project
leader and officer manager to address
concerns

During the 14-week project, nine PDSA cycles were completed. Each cycle
included an aim to guide the process. The first step or “Plan” included describing
what was the first or next test of change, listing the steps necessary to complete this
test, predicting what would happen during the test, and what measures would be used
to determine success. The “Do” step included implementing the test and describing
exactly what happened during the cycle. During the “Study” step the results of the
test were measured and compared to the predictions in order to learn from each cycle.
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Finally, the “Act” step included evaluating what was learned and planning
modifications to the plan for the next cycle (IHI, 2016). See Appendix K for the
individual 9 PDSA cycles.
Although the project leader had discussed the project with all providers and
staff throughout development, the first cycle was a formal introduction of the project
over a one-week period. The educational session was conducted, as described
previously. After the presentation and practice administering and scoring the EPDS
in small groups occurred, an opportunity was provided for discussion. All providers
and staff demonstrated how to administer and score the EPDS during practice
sessions. Providers and staff verbalized the concern that administering the EPDS at
the 9-month and 12-month well-child visits would be impractical as a time-intensive
infant developmental screen was already administered at these visits. All but two
providers, a pediatrician and pediatric nurse practitioner, expressed enthusiasm about
implementation of the project. Specifically, they were concerned that since the
mother was not a patient of the practice this would place them at legal risk if the
mother screened positive for being at-risk for depression. After receiving this
feedback, it was decided to implement PPD screening at the 2 week, 2 month, 4
month, and 6 month well-child visits. Although this was a change from the initial
project plan, it was consistent with a recommendation from the Ohio chapter of the
AAP which recommended screening for PPD at the 2 week, 2 month, 4 month, and 6
month well-child visits (American Academy of Pediatrics, Ohio Chapter, 2017). To
address the concerns expressed by the two providers, additional meetings were held
with the project leader, office manager, and providers to review the evidence and
recommendations supporting the project.
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During PDSA cycle 2, implementation of PPD screening with two providers
was initiated over a one-week period. In addition, the project leader and a pediatric
nurse practitioner with EMR expertise, created documentation for PPD screening
within the EMR. The documentation included whether documentation of the
screening, the EPDS score, and if resources and referral were completed as indicated.
Before the providers began screening the screening procedure, available resources and
appropriate documentation were reviewed with the providers. During this cycle two
mothers were identified as eligible to screen and both screens were completed.
Documentation in the EMR was completed for all screens. The results were reviewed
with the office and manager and providers and the providers verbalized confidence in
scoring and reviewing the EPDS results with mothers in a timely manner. It was
decided that implementation of the project would continue for the next two weeks and
an additional provider would begin screening.
Before the third PDSA cycle began the screening procedure, resources, and
appropriate documentation in the EMR was reviewed with the additional provider.
During this test, 10 mothers were eligible for screening and two screens were
completed. All screens were documented in the EMR. The results were reviewed
with the office manager and providers. The providers felt that since mothers were
provided the EPDS by the LPN as they came to the exam room that there was not
adequate time for the screen to be completed before they began their visit. After
discussing possible solutions, it was determined that the EPDS would be given to the
mother at check-in by the receptionists to allow further time for completion. The
implementation would continue with this new procedure and the addition of another
provider for the next week.
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During the fourth PDSA cycle an additional provider began screening which
brought the total to four providers. Again, the screening procedure, available
resources and documentation in the EMR was reviewed with this provider. In
addition, the change to provide mothers with the EPDS at check-in was discussed
with the staff. During this one-week cycle, 10 mothers were eligible for screening
and nine completed a screen. Documentation was completed for seven of the screens
in the EMR. While reviewing the results with the providers and office staff everyone
felt that providing the EPDS at check-in increased the likelihood of the screen being
completed and allowed the providers to score and review the screen with mothers in a
timely manner. It was determined that two more providers would begin screening
during the next test of change and that the EPDS would continue to begin to the
mother at check-in.
Before beginning the fifth PDSA cycle the screening procedure, available
resources, and appropriate documentation in the EMR was reviewed with the
additional providers. This test occurred over a two-week period with 34 mothers
eligible for screening and 21 screens completed. Documentation of screening in the
EMR was completed for 18 screens. The results from this test were reviewed with the
office manager and providers with providers stating that some mothers were not
completing the screens and per the project protocol they were not prompting the
mothers further. The providers also stated that they were receiving positive feedback
about the screening from mothers who completed the EPDS and all of the providers
expressed confidence in scoring and reviewing the EPDS with mothers.
Implementation of the project was scheduled to continue for another cycle with the
addition of two providers.
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During the sixth PDSA cycle, with the addition of two more providers, all
providers in the office were scheduled to be screening for PPD at eligible visits.
During this two-week test, 52 mothers were eligible for screening and 33 screens were
completed. All screens were documented in the EMR. After the results were
reviewed with the office manager and providers it was revealed that one of the
providers, a pediatric nurse practitioner, had communicated to the staff not to provide
eligible mothers with the EPDS as she was not comfortable with screening and would
be beginning maternity leave within the next few weeks. All other providers
continued to express confidence in scoring and reviewing the EPDS with mothers and
stated that they were receiving positive feedback from mothers who were screened.
The office manager met privately with the provider who refused to screen and
communicated that all providers were expected to provide screening at this time. The
next cycle was scheduled to continue implementation of the project with all providers.
The seventh PDSA cycle was completed over two weeks with all providers
involved at this time, except for the provider who had refused to screen and had
subsequently started maternity leave. Thirty-seven mothers were eligible to screen,
30 screens were completed, and all screens were documented in the EMR. During the
review of the cycle providers continued to express confidence in scoring and
reviewing the EPDS with mothers and also continued to receive positive feedback
from mothers. Implementation of the project, without changes, was set to continue in
the next cycle.
For the eighth PDSA cycle all providers continued to screen. There were 61
mothers eligible to screen and 42 screens were completed. Documentation in the
EMR was completed for all screens. While reviewing results of the cycle the office
manager reported that she had received feedback from an obstetrician’s office. The
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office reported that one of their patients was screened for PPD at a well-child visit and
returned to their office for evaluation and treatment. They expressed gratitude that the
office was offering PPD screening to mothers. Everyone expressed satisfaction with
this feedback and with the screening process as it had been implemented. For the next
cycle, all providers would continue screening.
The ninth PDSA cycle was the final cycle and all providers were screening at
this time. Although project outcomes and plans for sustainability had been discussed
informally throughout the project, the office manager made arrangements for an office
meeting with providers and staff to review these items as well as the results from the
final test. During this cycle, there 49 mothers eligible to screen and 21 screens
completed. All screens were documented in the EMR. During review of the
screening numbers for this test it was discovered that the two regular receptionists had
each been on vacation on alternate weeks. The person who substituted for them was
not familiar with the process of providing mothers with the EPDS at check-in and it
was felt that this led to the decrease in completed screens.
Preliminary project outcomes were also reviewed at this time and there was
unanimous agreement among the providers and staff that screening for PPD had been
a positive experience and that the practice would continue to offer screening. The
office manager had already spoken with the provider who had previously refused to
screen and established clear expectations for screening when she returned from
maternity leave. As the documentation was already in the EMR and resources were
available the project was stable and could continue without changes. The project
leader expressed appreciation for the cooperation of the providers, office manager,
and staff during the project and congratulated them for their hard work and successes.
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Plans were made for a future meeting where the project leader would share outcomes
from the project after review and data analysis.
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IV.

PROJECT EVALUATION

During implementation of this evidence based practice improvement project,
data were collected during the multiple PDSA cycles as recommended by Levin et al.
(2010). This was an essential step in order to adequately evaluate the outcomes for
this project. Outcome measures for this three-month project included the number of
mothers eligible to screen for PPD, the number of mothers who completed a screen
for PPD, and documentation in the EMR. Demographic data was also collected and
included the mother’s age, mother’s race, marital status, the infant’s age, the infant’s
gestational age, the type of infant feeding, and the type of insurance.
Data Collection
Data collection was accomplished by retrospective chart review. Informed
consent was not required for this proposed project; however, an information letter was
provided to every eligible participant (Appendix F). Data was collected by the DNP
student, biweekly during project implementation and at the conclusion of the project.
Data was entered into the data collection tool (Appendix L) and subsequently entered
into a password protected Excel spreadsheet. At no time were any protected health
information identifiers, which linked the infant or mother’s information, entered on
either the data collection sheet or the Excel spread sheet. A flash drive was used for
routine storage and transportation of data. When the drive was not in use, it was
stored in a locked file cabinet in the DNP student’s home office.
Data Analysis
At the conclusion of the project, all de-identified data was placed in an Excel
spreadsheet. The statistician was consulted for data analysis to ascertain statistical
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and clinical significance. Analysis of descriptive statistics was conducted on the
available data.
Although there was insufficient data to perform logistic regression on the
dependent variable (screening result) and the seven independent variables (mother’s
age, mother’s race, marital status, age of infant, gestational age of infant, infant
feeding, and type of insurance) at one time, logistic regression was conducted with
each individual variable.
Results
Demographics. During the 14-week project, 160 mothers completed the
EPDS. The age of mothers ranged from 17 to 40 years, with a mean age of 28 years
(SD = 5.08). Logistic regression analysis showed that the mother’s age was a
significant predictor of PPD (p = .035, df= 1). The coefficient was negative which
indicated that as age increased the likelihood of being at risk for postpartum
depression decreased, OR = .907, 95% CI [.828-.993], p = .035. Therefore, for every
one year of increase in maternal age, the odds of screening positive for PPD decreased
by 9.3%. Figure 1 shows the age of mothers screened during the project.
The race of the majority of subjects in the project was white (94.4%, n = 151).
Since there were few minorities, subjects were coded as either “white” or “not white”
and a logistic regression was analyzed for the variables of race and postpartum
depression. Race was a significant predictor of postpartum depression, OR = 4.691,
95% CI [.053-.856], p = .029. However, the effect size was very small (R2 = .026)
and by no means implies that non-white subjects have the same experiences with
PPD. Table 12 describes the frequency of maternal race of project subjects.
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Figure 1: Age of mother
Table 12
Mother’s Race
Race
African-American
Asian
Caucasian
Total

Frequency
8
1
151
160

Percent
5.0
.6
94.4
100.0

Cumulative Percent
5.0
5.6
100

A majority (59%, n = 95) of mothers who completed the EPDS were married.
Logistic regression analysis showed that marital status was not a significant predictor
of PPD (p =.07). Marital status is depicted in Table 13.
Table 13
Marital Status
Marital Status
Divorced
Married
Single
Total

Frequency
3
95
62
160

Percent
1.9
59.4
38.8
100.0

Cumulative Percent
1.9
61.3
100.0

The age of infants brought by mothers for well-child visits ranged from 2
weeks to 24 weeks. The mean age of infants was 10.8 weeks (SD = 7.74). Logistic
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regression analysis showed that the age of the infant was not a significant predictor of
maternal PPD (p = .46). The frequency of age of infants in weeks is depicted in
Figure 2.

Figure 2: Infant’s age.

The gestational age of the infant at birth was also collected. Gestational age
ranged from 31 weeks to 41 weeks with a mean of 38.7 weeks (SD = 1.31) indicating
the majority of participant’s infants were term at birth. Logistic regression analysis
indicated that the gestational age of the infants was a significant predictor of PPD in
mothers (p = .050, df = 1). The coefficient was negative which indicated that as the
gestational age of the infant increased the likelihood of being at risk for postpartum
depression decreased, OR = .747, 95% CI [.558-1.000], p = .050. Therefore, for
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every week of increase in gestational age, the odds of the mother screening positive
for PPD decreased by 25.3%. Figure 3 depicts the gestational age of infants.

Figure 3: Gestational age of infant.
The type of feeding method (breastfed or bottle fed) that infants received was
collected. A majority (60%, n = 97) of infants were breastfed. Logistic regression
analysis showed that the type of feeding was not a significant predictor of maternal
PPD (p = 0.23). Type of infant feeding is shown in Table 14.
Table 14
Type of Infant Feeding
Type of Feeding
Frequency
Breastmilk
97
Formula
63
Total
160

Percent
60.6
39.4
100.0

Cumulative Percent
60.6
100.0

The type of insurance for the infant was collected with a majority (63%, n =
101) of infants being covered by private insurance. Logistic regression analysis

58

showed that the type of insurance was a significant predictor of PPD in mothers (p =
.043, df = 1). The coefficient was negative which indicated that having insurance
through Medicaid increased the likelihood of being at risk for postpartum depression
decreased, OR = .414, 95% CI [.117-.971], p = .043. Therefore, subjects who did not
have Medicaid, but private insurance would decrease the odds of screening positive
for PPD by 58.6%. Table 15 depicts the type of insurance.
Table 15
Type of Insurance
Insurance
Medicaid
Private
Self-pay
Total

Frequency
57
101
2
160

Percent
35.6
63.1
1.3
100.0

Cumulative Percent
35.6
98.8
100.0

EPDS Scores
Total Score. The EPDS instrument total score could range from zero (no
signs of depression) to 30 (extreme signs of depression). EPDS scores ranged from
zero to 21 with a mean score of 5.29 (SD = 4.37). Scores collected during the project
are shown in Figure 4.
Screen Results. The score obtained from the EPDS indicates whether or not a
mother is at risk for PPD. During this project, approximately 16% (n = 26) of
mothers were identified to be at risk for PPD. Table 16 depicts EPDS screen results.
Table 16
EPDS Screen Results
EPDS Results
Negative for PPD risk
Positive for PPD risk
Total

Frequency
134
26
160

Percent
83.8
16.3
100.0

Cumulative Percent
83.8
100.0

Potential for Self-Harm. Question 10 of the EPDS assess suicidal thoughts
and was reviewed separately. Of the 160 mothers screened, there were three (1.9%)
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Figure 4: EPDS scores

positive responses. The responses to question 10 are shown in Table 17.
Table 17
Response to Question 10
Response to Question 10
Yes
No
Total

Frequency
3
157
160

Percent
1.9
98.1
100.0

Cumulative Percent
1.9
100.0

EPDS Screening Results
During the 14-week project, 255 mothers were identified as eligible for PPD
screening and 160 mothers completed the screen (62.74%). The frequency of
screening, by week, is depicted in Table 18.
A run chart is an important tool in quality improvement as it displays changes
in data over time. This is especially useful in showing how well a process is, or is
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Table 18
Frequency of PPD Screening by Week
Week
Eligible to Screen
Week 1
2
Week 2
7
Week 3
3
Week 4
10
Week 5
15
Week 6
19
Week 7
20
Week 8
32
Week 9
10
Week 10
27
Week 11
24
Week 12
37
Week 13
20
Week 14
29
Total

Completed Screen
2
1
1
9
8
13
17
16
10
20
18
24
11
10

Percent Screened
100.0%
14.3%
33.3%
90.0%
53.3%
68.4%
85.0%
50.0%
100.0%
74.1%
75.0%
64.9%
55.0%
34.5%

160

62.7%

255

not, performing and what changes or adaptions may be needed for further
improvement (Institute for Healthcare Improvement [IHI], 2017). Figure 5 shows the
percentage of mothers screened for PPD, by week, during implementation of the
project.
PNP on maternity
leave

1provider added
& EPDS at
check in

Goal

Median

2 more
providers
added

All providers
screening, 1PNP refuses
Reg.
check in
staff on
vacation

1provider
added

Figure 5: Percent of mothers screened for PPD within 3 months
7
61

EMR Documentation
Documentation in the EMR of the results of screening and providing resources
and referrals, as indicated, was also collected. Table 19 shows results on a weekly
basis.
Table 19
Documentation in the EMR
Week
Screen
Week 1
2
Week 2
1
Week 3
1
Week 4
9
Week 5
8
Week 6
13
Week 7
17
Week 8
16
Week 9
10
Week 10
20
Week 11
18
Week 12
24
Week 13
11
Week 14
10

Documented
2
1
1
6
5
13
17
16
10
20
18
24
11
10
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Percent Documented
100%
100%
100%
67%
63%
100%
100%
100%
100%
100%
100%
100%
100%
100%

V.

DISCUSSION

Findings from Project Implementation
The purpose of this evidence-based practice improvement project was to
implement PPD screening for mothers who bring their infants for well-child visits,
during the first year of life, at a private pediatric practice. The aim was that within
three months of project implementation providers would screen for PPD, using the
EPDS, at greater than or equal to 80 percent of the time. The outcomes measured
included the number of mothers eligible for PPD screening, the actual number of
mothers who completed screening, and documentation of screening and provision of
resources and referrals in the EMR. Demographic information was also collected as
previously discussed.
Results
After the first PDSA cycle it was determined by the providers, staff, and office
management that screening at the 9 month and 12 month well-child visits was not
feasible since an intense infant developmental screen was administered at these visits.
Therefore, the project was adapted to include PPD screening at the 2 week, 2 month, 4
month, and 6 month well-child visits.
Demographics. The average age of mothers screened for PPD during the
project was 28 years. While the analysis showed that there was an increased risk for
PPD as the mother’s age decreased, findings suggested that age accounted for only
3% of the variability in screening positive for PPD. This is consistent with findings
by Aasheim et al. (2012) that age is not strong predictor of developing PPD. One of
the strongest risk factors for developing PPD is the mother’s history of depression
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during any point in her life and this increases the risk of PPD in all ages (Roy-Byrne,
2016).
Mothers who participated in this project were overwhelmingly Caucasian
(94%) and although this was determined to be a positive predictor for screening
positive for risk of PPD, the effect size was very small as previously noted. Since the
setting for the project is comprised of primarily Caucasian patients (90%) it is not
surprising that the majority of mothers screened were also Caucasian. This finding is
also not consistent with research indicating that women of all races are at risk for
developing PPD (National Institute of Mental Health, 2017).
The majority (59%) of mothers screened for PPD were married and marital
status was not identified as a significant predictor for being at risk for PPD. While
marital status alone may not be risk factor, mothers who lack emotional support from
a spouse, partner, family or friends have been shown to have an increased risk for
PPD (National Institute of Mental Health, 2017).
The median age of infants that mothers brought to the office for well-child
visits during the project was 10.8 weeks, with a range of two to 24 weeks. Infant age
was not shown to be a predictor for increasing the risk of mothers developing PPD.
This is consistent with the findings of Chaudron, Kitzman, Szilagyi, Sidora-Arcoleo
and Anson (2006) that PPD persists throughout the first year on an infant’s life.
The gestational age of infants included in the project ranged from 31 to 41
weeks with an average age of 38.7 weeks. Infants born at less than 37 weeks of
gestation are considered premature. Analysis from this project demonstrated that
mothers with infants born at a lower gestational age were at increased risk for
screening positive for PPD. Although the effect size was small, this finding is
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consistent with current findings that premature infants increase the risk of PPD for
mothers (Wu, Hung & Chang, 2015).
Method of feeding was assessed with a majority (60%) being breastfed. Type
of feeding was not found to be a predictor of increasing a mother’s risk for PPD. This
is consistent with recent findings by Pope, Mazmanian, Bédard, and Sharma (2016)
which showed that breastfeeding attempt and the duration of breastfeeding is not
associated with the subsequent development of PPD.
Lastly, the type of insurance was also recorded and was predictive of
screening positive for postpartum depression. Mothers of infants whose insurance
was Medicaid were at a higher risk for being positive for PPD. Although this was a
significant finding the effect size was small. However, this is consistent with findings
described by Earls (2010) that mothers from lower socioeconomic groups report
higher rates of PPD.
EPDS Scores. During the project, EPDS scores ranged from zero to 21 with a
mean of 5.3. Of the 160 mothers screened 16% were identified to be at risk for PPD.
Although slightly higher, this is still consistent with the prevalence of PPD at the
national (10-15%), state (12.4%), and local levels (11.5%), (National Institute for
Healthcare Management, 2010; Ohio Department of Health, 2015).
The response to question 10 of the EPDS was recorded separately as this
question assesses suicidal thoughts and should always be reviewed independently.
During the project, there were three affirmative responses (1.9%) to this question.
Each mother responded “sometimes” to this question and when questioned further
denied active suicidal ideation. Each mother was also accompanied at the
appointment by her spouse. Once the EPDS was reviewed and it was determined that
the mother was not experiencing active suicidal ideation, the provider remained in the
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examination room with the mother, spouse, and infant while the mother’s primary
care provider was contacted and a follow-up appointment was scheduled for that day.
At no time was the mother left alone. The mother left the office accompanied by her
spouse with a follow-up appointment scheduled and resources, including a suicide
hotline number, provided to her. The importance of reviewing this question
separately cannot be overstated as suicide has been identified as the seventh leading
cause of maternal death (Lewis, et al., 2011).
Project Outcomes. The goal for the project was for 80% of mothers to be
screened for PPD. As the run chart demonstrates the median over the 14-week project
was 67% and the goal of 80% was met or exceeded for four of the 14 weeks. Several
factors contributed to not meeting the goal for this project.
After the third PDSA cycle it was determined that providing the mother the
EPDS when she came to the examination room did not allow adequate time to
complete the screen and for the provider to review the results with her. Therefore, the
screen was given to mothers when they came to the front desk to check in for their
appointment. This increased the number of screens completed (90%) for the first
week after implementing this change. However, with the addition of two providers in
the next PDSA cycle the number of completed screens dropped below the goal of
80% again. Feedback from providers revealed that some mothers were not
completing the screening and per the project protocol they were not prompting the
mothers further.
Another unforeseen barrier to implementation was the refusal of one provider,
a pediatric nurse practitioner, who notified the office staff not to provide eligible
mothers on her schedule with the EPDS. This provider had verbalized reluctance to
participate in the project during the initial PDSA cycle and further discussions
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between the provider, project leader, and officer manager were held. The results of
this can be seen during week eight of the project when screening rates decreased to
50%. Once the results were reviewed, the office manager met privately with this
provider and communicated that all providers were expected to implement screening
at this this time. This provider began maternity leave the following week and
remained out of the office for the remainder of the project. The percentage of mothers
screened for PPD improved with the absence of this provider, however the percentage
declined again during this final weeks of the project.
There was also a significant decline in completed screens during the final two
weeks of project implementation. While reviewing the outcomes from PDSA cycle 9
it was discovered that the two front desk staff who provided mothers with the EPDS
had been on vacation on alternate weeks. The staff member who filled in for these
individuals was not familiar with the procedure for providing the EPDS to mothers
when they checked in for their visits. This resulted in missed opportunities and
decreased the rate of screening for the final PDSA cycle.
There is another factor that may have contributed to not achieving the goal of
screening 80% of eligible mothers for PPD. This private pediatric office has a high
rate (25-30%) of parents who refuse or follow an alternate schedule of vaccinations
for their children (K. Ely, personal communication, June 12, 2017). Boom and
Cunningham (2014) studied parents who delay or refuse vaccines for their children
and found several common characteristics which include: white race, higher income
levels, maternal age over 30, and higher educational levels. These characteristics are
consistent with the population in this pediatric office and it is possible that these same
mothers may refuse to complete screening for PPD which will lead to an inability to
achieve the 80% goal.

67

Documentation of PPD screening and the provision of resources to mothers in
the EMR was 100% except for two weeks during the project and this occurred when
new providers were introduced into a new PDSA cycle. Because the documentation
was built into the EMR it was not difficult for providers to complete the required
documentation and only required reminders while reviewing results of the PDSA
cycle.
Ultimately all providers and staff, except the one provider who refused to
implement PPD screening, verbalized satisfaction with the screening process and
were comfortable scoring the EPDS and reviewing the results with mothers. In
addition, the office received positive feedback from mothers during the project.
Mothers who screened positive for being at risk for PPD verbalized gratitude for
having the opportunity to address their concerns and receive resources and
information on further evaluation and treatment. One mother, who screened negative
for PPD at her infant’s four-month well-child visit, expressed gratitude for being
screened. She had been diagnosed and treated for PPD at two months postpartum and
stated that screening negative at this visit was reassuring that her treatment was
successful.
In addition, the office manager received several phone calls from mothers’
primary care providers after they had seen the mothers screened in the office who
were identified to be at risk for PPD. These providers were grateful for the
opportunity to follow-up with these patients and address their concerns.
Summary of Findings
Although this evidence-based practice improvement did not consistently
achieve the aim for screening 80% of eligible mothers for PPD over the three-and-ahalf-month project period, the project was still considered to be successful by
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providers, staff, management, and most importantly the mothers who were screened.
At the conclusion of the project it was decided that the office will continue to screen
for PPD at the 2 week, 2 month, 4 month, and 6 month visits using the EPDS and
providing the resources and referrals as implemented throughout the project.
Sustaining the practice of screening mothers for PPD at well-child visits was
considered throughout the development of the project. First, developing
documentation of screening and providing resources into the EMR allows providers to
incorporate this process into their practice without significantly increasing their
workload. Secondly, the decision-making algorithm and resources for mothers are
conveniently located in provider offices so that they can be accessed easily quickly.
Finally, the office manager will review monthly reports for each provider identifying
the number of mothers eligible for screening and number of completed screens. This
information will be reviewed at monthly provider meetings.
Lessons Learned & Future Recommendations
The importance of clear and consistent communication with office
management, providers, and staff during the development and implementation of an
evidence-based practice improvement project cannot be overemphasized. It is
through this communication that trust is built and the project is not viewed as merely
an academic exercise, but rather it is seen as an essential step in improving patient
outcomes which is the ultimate goal of evidence-based practice.
As PPD screening continues in this office it is important to regularly address
the concerns of providers who verbalize reluctance to screening and to communicate
expectations clearly. In addition, as new or temporary staff work in the office it is
essential that they be aware of office procedures so that this change in practice can be
sustained.
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Because the project was implemented in a private pediatric office with an
overwhelmingly Caucasian patient population, it is unrealistic to assume that the same
challenges or findings would be similar in a different setting. Therefore, further
implementation of PPD screening in diverse settings is recommended.
Another limitation of the project is the length of time that all providers in the
office were offering PPD screening to mothers. It was not until the sixth PDSA cycle,
which began during week six of the project, that all providers were included in the
screening process. By continuing the project for a longer period of time it would have
been possible to obtain further feedback from providers and make changes to the
process as indicated. Ultimately, the results from this project may be useful to
providers who are interested in establishing PPD screening at well-child visits in
similar settings.
Dissemination of Findings
The final step of the EBPI model is the dissemination of best practices (Levin
et al., 2010). As Betz, Smith, Melnyk and Olbrysh (2015) assert, “new evidence will
not achieve its maximum value to practice and better patient outcomes unless it is
communicated effectively” (p. 391).
Findings from this project were shared regularly with participants in the
project during multiple PDSA cycles. A meeting with the all office members will
occur after the final defense of the project to review the project outcomes.
Further dissemination via poster presentations at relevant professional
meetings and manuscript submissions to scholarly journals will be actively pursued.
Conclusion
PPD and its negative effects on maternal and infant health is well documented.
Pediatric providers have the most contact with mothers throughout the first year of an
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infant’s life and therefore have a unique opportunity to intervene by offering frequent
and consistent screening for PPD. The implementation of an evidence-based practice
improvement project at a private pediatric office is a feasible option for identifying
mothers at risk for PPD, providing them with resources, and referring them to their
primary care provider for further evaluation and treatment.
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Appendix A
Edinburgh Postnatal Depression Scale

Edinburgh Postnatal Depression Scale1 (EPDS)
Name: ______________________________

Address: ___________________________

Your Date of Birth: ____________________

___________________________

Baby’s Date of Birth: ___________________

Phone:

_________________________

As you are pregnant or have recently had a baby, we would like to know how you are feeling. Please check
the answer that comes closest to how you have felt IN THE PAST 7 DAYS, not just how you feel today.
Here is an example, already completed.
I have felt happy:
Yes, all the time
Yes, most of the time
No, not very often
No, not at all

This would mean: “I have felt happy most of the time” during the past week.
Please complete the other questions in the same way.

In the past 7 days:
1. I have been able to laugh and see the funny side of things
As much as I always could
Not quite so much now
Definitely not so much now
Not at all

*6. Things have been getting on top of me
Yes, most of the time I haven’t been able
to cope at all
Yes, sometimes I haven’t been coping as well
as usual
No, most of the time I have coped quite well
No, I have been coping as well as ever

2. I have looked forward with enjoyment to things
As much as I ever did
Rather less than I used to
Definitely less than I used to
Hardly at all
*3. I have blamed myself unnecessarily when things
went wrong
Yes, most of the time
Yes, some of the time
Not very often
No, never
4.

*5

I have been anxious or worried for no good reason
No, not at all
Hardly ever
Yes, sometimes
Yes, very often
I have felt scared or panicky for no very good reason
Yes, quite a lot
Yes, sometimes
No, not much
No, not at all

*7

I have been so unhappy that I have had difficulty sleeping
Yes, most of the time
Yes, sometimes
Not very often
No, not at all

*8

I have felt sad or miserable
Yes, most of the time
Yes, quite often
Not very often
No, not at all

*9

I have been so unhappy that I have been crying
Yes, most of the time
Yes, quite often
Only occasionally
No, never

*10

The thought of harming myself has occurred to me
Yes, quite often
Sometimes
Hardly ever
Never

Administered/Reviewed by ________________________________ Date ______________________________
1

Source: Cox, J.L., Holden, J.M., and Sagovsky, R. 1987. Detection of postnatal depression: Development of the 10-item
Edinburgh Postnatal Depression Scale.
British Journal of Psychiatry 150:782-786 .

2

Source: K. L. Wisner, B. L. Parry, C. M. Piontek, Postpartum Depression N Engl J Med vol. 347, No 3, July 18, 2002,
194-199
Users may reproduce the scale without further permission providing they respect copyright by quoting the names of the
authors, the title and the source of the paper in all reproduced copies.
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Appendix B
Agency Permission for Conducting Doctoral Project
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Appendix C
Dayton Children’s Hospital IRB Determination Letter
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Appendix D
PowerPoint Presentation Handout

Content
Problem Identification
Purpose and Goals
Guiding Framework
Review of the Literature
Recommendations for Practice Change
Implementation and Evaluation Plan
Summary/Conclusion

SCREENING MOTHERS FOR
POSTPARTUM DEPRESSION AT
WELL-CHILD VISITS IN A PRIVATE
PEDIATRIC CLINIC: AN EVIDENCEBASED PRACTICE IMPROVEMENT
PROJECT
Cassie Fishbein, MS, CPNP

Problem Identification

Purpose

10 to 15% of women suffer from postpartum
depression (PPD) and symptoms frequently occur
after hospital discharge and after the postpartum
check up (Liberto, 2012).
Infants whose mothers have PPD are at greater
risk for anxiety, depressive and oppositional
disorders and delayed language development
(Apter-Levy, et al, 2013).
New mothers and their infants have contact with
pediatric health care providers at least eight times
in a child’s first two years if recommended visits
are completed (Liberto, 2012).

Implement a PPD screening program for
mothers who bring their infants for well-child
visits, during the first year of life, at a private
pediatric practice

Setting and Population

Goals

Setting

Identifying mothers at risk for PPD and
providing them with community resources and
referrals to their primary care provider for
further evaluation and treatment

private pediatric practice in the Midwest located in
a small town in a rural community

Population
neonates, infants and mothers who present for
well-child visits at the following scheduled
intervals: two weeks, two months, four months,
six months, nine months and 12 months of age
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Appendix E
Teaching Plan for Staff and Provider Education
Time
allowed
45 minutes

Learning
outcomes
Describe
principles of
EBP
Recognize
significance of
PPD and need
for screening
Describe use of
EPDS in
screening for
PPD
Interpret results
of EPDS

Content
Principles of
EBP

Methods and
Materials
Power Point
presentation

Symptoms of
PPD

EPDS
Screening tool

Adverse
effects of PPD
on mothers,
infants and
families

Practice using
and
interpreting
EPDS
screening

Use of EPDS
to screen for
PPD

Decision
making
algorithm

Action plan
for positive
screening
result

Community
resources for
mothers with
positive
screening
results

Resource and
referral
options
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Evaluation
Method
Discussion
through Q &
A
Case study
Role play

Appendix F
Information Letter for Participation in a Quality Improvement Project
Title: Screening Mothers for Postpartum Depression at Well-Child Visits in a
Private Pediatric Clinic: An Evidence-Based Practice Improvement Project
Principal Investigator: Cassie Fishbein, MS, CPNP
Contact Telephone: (937) 272-1965
You are invited to participate in a quality improvement project. The purpose of
this project is to screen mothers for postpartum depression (PPD) at well-child visits
and to provide information and resources to mothers with positive screens for PPD.
The recognition and treatment of PPD has the potential to benefit mothers, neonates,
infants and their families. You were selected as a possible participant because you are
seeking well-child care for your neonate or infant at Child and Adolescent Specialty
Care.
What will be involved if you participate? You will be offered to complete a brief,
10-item depression screen, the Edinburgh Postnatal Depression Scale, when you bring
your neonate or infant for their 2 week, 2 month, 4 month, and 6 month well-child
visit. This self-administered screen, which takes approximately five minutes to
complete, will be scored and reviewed with you by a pediatric provider. If the screen
indicates that a risk for PPD is present, you will be provided with information and
resources for further evaluation and treatment.
Are there any risks or discomforts? While there are no physical risks associated
with this screen there is the possibility for emotional discomfort. Several steps will be
taken to maintain confidentiality of protected health information. Random numbers
will be assigned to replace names and all information will be stored on a flash drive
and kept in a locked drawer. The investigator will be the only person with access to
this information. There may be other risks which are unknown at this time.
Are there any benefits to yourself or others? Identifying PPD can lead to further
evaluation and treatment. This has the potential to benefit not only you but your
neonate, infant and family. PPD can lead to negative effects for children including
anxiety, depression and oppositional conduct disorders, and delayed language
development. Early recognition and treatment can reduce these effects.
Are there any costs? There are no costs to you for participating in this project. You
will not receive financial compensation for your participation.
What other options are there? You may choose not to participate in this project.
Can you change your mind? Your participation is completely voluntary and you
may withdraw from the project at any time by sending written notice to the principal
investigator, Cassie Fishbein at http://fishbein.2@wright.edu. Your decision about
whether or not to participate will not jeopardize your future relations with Child and
Adolescent Specialty Care.
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The information about you collected for this research will be protected by
removing any patient or participant identifiers once data collection is complete. All
study information will be stored in secured research files on a flash drive and
identified by a code number. The principal investigator will have access to your
protected health information. If results of this project are reported in journals, at
scientific meetings, or used for educational purposes, the people who participated in
this project will not be identified.
If you have questions about this project please ask them now or you may contact
the principal investigator at (937) 272-1965.
HAVING READ THE INFORMATION PROVIDED, IT IS YOUR CHOICE TO
DECIDE IF YOU WANT TO PARTICIPATE IN THIS QUALITY
IMPROVEMENT PROJECT. IF YOU DECIDE TO PARTICIPATE, THE CHOICE
TO COMPLETE THE EDINBURGH POSTNATAL DEPRESSION SCALE WILL
SERVE AS YOUR AGREEMENT TO DO SO.
THIS INFORMATION LETTER IS YOURS TO KEEP.

_______________________________________
Principal Investigators Signature and Date
_______________________________________
Print Name and Date
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Appendix G
Postpartum Support International (PSI) Brochure
HOW ARE YOU FEELING NOW?

THINGS YOU CAN DO

While many women experience some mild
mood change or “the blues” during or
after the birth of a child, 1 in 7 women
experience more significant symptoms of
depression or anxiety. 1 in 10 Dads
become depressed during the first year.

Being a good parent includes taking care
of yourself. If you take care of yourself,
you will be able to take better care of your
baby and your family.
•

Talk to a counselor or healthcare provider
who has training in perinatal mood and
anxiety problems.

•

Learn as much as you can about
pregnancy and postpartum depression
and anxiety.

•

Get support from family and friends.
Ask for help when you need it.

•

Join a support group in your area or
online.

•

Keep active by walking, stretching or
whatever form of exercise helps you to
feel better.

•

Get enough rest and time for yourself.

PARENTS:
Are you feeling sad or depressed?
Is it difficult for you to enjoy yourself?
Do you feel more irritable or tense?
Do you feel anxious or panicky?
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Are you having difficulty bonding
with your baby?
Do you feel as if you are "out of control"
or "going crazy”?
Are you worried that you might hurt
your baby or yourself?
FAMILIES:
Do you worry that something is wrong
but don’t know how to help?

•

Eat a healthy diet.

Do you think that your partner
or spouse is having problems
coping?

•

Don’t give up! It may take more than
one try to get the right help you need.

Are you worried that it may never
get better?

•
•

Call or email us; we will help you.

Any parent can suffer from pregnancy or
postpartum mood or anxiety disorders.
However, with informed care you can prevent
a worsening of symptoms and can fully
recover. It is essential to recognize symptoms
and reach out as soon as possible so that
you can get the help you need and deserve.

www.postpartum.net

Postpartum Support International
6706 SW 54th Avenue
Portland, OR 97219
Office: (503) 894-9453
Fax: (503) 894-9452
www.postpartum.net
Broch ure s a vaila ble in E n glish & Esp añ ol
Fin d the m a t w w w .po stpartum .net/resource s

Appendix H
Many Shades of Blue Brochure
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Appendix I
Decision Making Algorithm
Mother
Provided
EPDS

Mother
Completes
EPDS

EPDS Scored
by Provider
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EPDS <
10

Discuss
Results with
Mother

Document
in EMR

EPDS ≥
10

Discuss
Results with
Mother

EPDS +
for #10

Do not leave
mother and
infant alone

Refer mother to
her PCP and
provide
resources

Contact
911

Document
in EMR

Document
in EMR

Appendix J
Institute for Healthcare Improvement PDSA Worksheet
PDSA Worksheet for Testing Change

Aim: (overall

goal you wish to achieve)

Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:

Person
responsible

When to
be done

Where to
be done

Person
responsible

When to
be done
.

Where to
be done

Plan
List the tasks needed to set up this test of change
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Predict what will happen when the test is carried
out

Measures to determine if prediction succeeds

Do

Describe what actually happened when you ran the test

Study

Describe the measured results and how they compared to the predictions

Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Institute for Healthcare Improvement

Appendix K
PDSA Cycles 1- 9
PDSA Worksheet for Testing Change
Aim: Providers and office staff will gain knowledge regarding EBPI, screening for PPD, and use of the EPDS
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:
Initial introduction of the project to providers and staff

Person
responsible
DNP student

When to be
done
2/6/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

DNP student

.Jan 2017

DNP student
home office

Plan
List the tasks needed to set up this test of change
Prepare PowerPoint presentation
Prepare handouts including EPDS and community resources
Coordinate meeting times with office manager
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers and staff will receive information regarding the EBPI
process, the project, and gain competence in using the EPDS to
screen for PPD

Providers and staff verbalize understanding of the EPBI process and
project
Provider and staff demonstrate competence in administering and
scoring EPDS

Do

Describe what actually happened when you ran the test
Presentation and practice with administering and scoring EPDS were completed as planned. Providers and staff verbalized concern that
administering the EPDS at the 9-month and 12-month well-child visits would be impractical as time-intensive infant developmental screening occurred at these
visits. Two providers verbalized reluctance to implement the project as the mother was not the patient of the practice and they were concerned with legal
implications.
Study

Describe the measured results and how they compared to the predictions
With the exception of two providers, there was enthusiasm about implementation of the project. All providers and staff verbalized an
understanding of the EBPI process and project. All providers and staff demonstrated how to administer and score the EPDS.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Because of the infant developmental screens administered at the 9-month and 12-month well-child visits, it was decided to implement PPD
screening at the 2-week, 2-month, 4-month, and 6 month well-child visits. Additional meetings with the two providers who expressed concerns about the project
were held with the DNP student and office manager on 2/10/17.

Institute for Healthcare Improvement

PDSA Cycle 2
PDSA Worksheet for Testing Change
Aim: Implement screening for PPD with two providers at 80% of eligible visits for one week
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:

Person
responsible
DNP student
CPNPs

When to be
done
3/6/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

Review screening procedure, available resources, and appropriate documentation
with providers

DNP student

3/6/17

office

Create documentation for PPD screening within the EMR

DNP student and
CPNP

3/6/17

office

DNP
student/office
manager and
providers

3/10/17

office

Implementation of PPD screening with two providers for one week

Plan
List the tasks needed to set up this test of change

Review results with providers and office manager

97
Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened

Documentation of screening will be created in the EMR

Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
After reviewing materials with the providers and creating documentation within the EMR, PPD screening was implemented for one week. Data
was collected by retrospective chart review.
Study

Describe the measured results and how they compared to the predictions
Two mothers were identified as eligible to screen during this time and both screens were completed. Documentation in the EMR was completed
for all screens. Providers verbalized confidence in scoring and reviewing the results with mothers in a timely manner. Results were reviewed with the providers
and the office manager.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Implementation of the project to continue with the addition of a provider in the next week.

Institute for Healthcare Improvement

PDSA Cycle 3
PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with additional provider (three total) at 80% of eligible visits for two weeks
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:

Person
responsible
DNP student
CPNPs
MD

When to be
done
3/13/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

Review screening procedure, available resources, and appropriate documentation
with provider who will begin screening

DNP student and
MD

3/13/17

office

Review results with providers and office manager

DNP
student/office
manager and
providers

3/24/17

office

Continuation of PPD screening with the addition of additional provider

Plan
List the tasks needed to set up this test of change
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened
Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
After reviewing materials with the additional provider, PPD screening continued for two weeks. Data was collected by retrospective chart review.

Study

Describe the measured results and how they compared to the predictions
Ten mothers were identified as eligible to screen and two screens were completed. Documentation in the EMR was completed for all screens.
Providers verbalized confidence in scoring and reviewing the results with mothers in a timely manner. Results were reviewed with the providers and the office
manager. The providers believed that providing the EPDS to the mother when she came to the exam room did not allow adequate time for the screen to be
completed, scored, and reviewed during the visit.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
The EPDS will be given to the mother at check-in to allow further time for completion. Implementation of the project to continue with the addition
of a provider in the next cycle.

Institute for Healthcare Improvement

PDSA Cycle 4
PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with additional provider (four total) at 80% of eligible visits for one week
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:

Person
responsible
DNP student
CPNPs
MDs

When to be
done
3/27/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

Review screening procedure, available resources, and appropriate documentation
with provider who will begin screening

DNP student and
MD

3/27/17

office

Discuss changes with staff and provide EPDS to mothers at check in

DNP student

3/27/17

office

Review results with providers and office manager

DNP
student/office
manager and
providers

3/31/17

office

Continuation of PPD screening with the addition of additional provider
Provide mother with EPDS at check-in

Plan
List the tasks needed to set up this test of change
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened

Documentation of results and appropriate resources/referrals in the
Number of completed screens will increase by providing the EPDS to
EMR
mothers at check-in
Do
Describe what actually happened when you ran the test
After reviewing materials with the additional provider, PPD screening continued for one week. Discussions were held with staff regarding the
change of providing the EPDS to mothers at check-in. Data was collected by retrospective chart review.
Study

Describe the measured results and how they compared to the predictions
Ten mothers were identified as eligible to screen and nine screens were completed. Documentation in the EMR was completed for seven
screens. Results were reviewed with the providers and the office manager. The providers believed that providing the EPDS to the mother when she came to the
exam room increased the likelihood of the screen being completed and facilitated the review and scoring of the EPDS in a timely manner.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
The EPDS will continue to be given to the mother at check-in. Implementation of the project to continue with the addition of two providers in the

next cycle.
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PDSA Cycle 5

PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with additional providers (six total) at 80% of eligible visits for two weeks
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:

Person
responsible
DNP student
CPNPs
MDs

When to be
done
4/3/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

Review screening procedure, available resources, and appropriate documentation
with providers who will begin screening

DNP student and
MD

4/3/17

office

Review results with providers and office manager

DNP
student/office
manager and
providers

4/14/17

office

Continuation of PPD screening with additional providers

Plan
List the tasks needed to set up this test of change
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened
Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
After reviewing materials with the additional provider, PPD screening continued for two weeks. Data was collected by retrospective chart review.

Study

Describe the measured results and how they compared to the predictions
34 mothers were identified as eligible to screen and 21 screens were completed. Documentation in the EMR was completed for 18 screens.
Results were reviewed with the providers and the office manager. Providers stated that some mothers were not completing the screens and per the project
protocol they were not prompting them further. The providers also stated that they were receiving positive feedback about the screening from mothers who
completed the EPDS. All providers felt confident in scoring and reviewing the EPDS with mothers.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Implementation of the project to continue with the addition of two providers in the next cycle, which will include all providers in the practice.
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PDSA Cycle 6
PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with additional providers (eight total) at 80% of eligible visits for two weeks
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:

Person
responsible
DNP student
CPNPs
MDs

When to be
done
4/17/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

Review screening procedure, available resources, and appropriate documentation
with providers who will begin screening

DNP student
MD
CPNP

4/17/17

office

4/28/17

office

Review results with providers and office manager

DNP
student/office
manager and
providers

Continuation of PPD screening with the addition of two providers

Plan
List the tasks needed to set up this test of change
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened
Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
After reviewing materials with the additional providers, PPD screening continued for two weeks. All providers in the office will be involved in the
project at this time. Data was collected by retrospective chart review.
Study

Describe the measured results and how they compared to the predictions
52 mothers were identified as eligible to screen and 33 screens were completed. Documentation in the EMR was completed for all screens.
Results were reviewed with the providers and the office manager and it was discovered that one of the providers had communicated to staff not to provide eligible
mothers with the EPDS as she was not comfortable with screening and would be out on maternity leave within the next few weeks. All other providers felt
confident in scoring and reviewing the EPDS with mothers and stated that they continued to receive positive feedback from mothers who were screened.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Implementation of the project to continue with all providers screening in the next cycle. The office manager met privately with the provider who
refused to screen on 4/28/17 and communicated that all providers were expected to implement screening at this time.
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PDSA Cycle 7
PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with all providers at 80% of eligible visits for two weeks
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:
Continuation of PPD screening with all providers participating

Person
responsible
DNP student
CPNPs
MDs

When to be
done
5/1/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

DNP
student/office
manager and
providers

5/1/17

office

5/12/17

office

Plan
List the tasks needed to set up this test of change
Review results with providers and office manager
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened
Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
All providers are involved in the project at this time. Data was collected by retrospective chart review.

Study

Describe the measured results and how they compared to the predictions
37 mothers were identified as eligible to screen and 30 screens were completed. Documentation in the EMR was completed for all screens.
Results were reviewed with the providers and the office. All other providers felt confident in scoring and reviewing the EPDS with mothers and stated that they
continued to receive positive feedback from mothers who were screened. There was on mother who responded yes to question 10 on the EPDS. The response
was “sometimes” to the question of self-harm. The mother was accompanied by her spouse and the mother’s primary-care giver was contacted while the provider
was in the exam room and a follow-up appointment was scheduled for the following day. The mother left the office with resources, accompanied by her spouse,
and with instructions on seeking emergency care as indicated. The provider who refused to screen was out on maternity leave effective 5/1/17.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Implementation of the project to continue with all providers screening in the next cycle.
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PDSA Cycle 8
PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with all providers at 80% of eligible visits for two weeks
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:
Continuation of PPD screening with all providers participating

Person
responsible
DNP student
CPNPs
MDs

When to be
done
5/15/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

DNP
student/office
manager and
providers

5/26/17

office

Plan
List the tasks needed to set up this test of change
Review results with providers and office manager
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened
Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
All providers are involved in the project at this time. Data was collected by retrospective chart review.

Study

Describe the measured results and how they compared to the predictions
61 mothers were identified as eligible to screen and 42 screens were completed. Documentation in the EMR was completed for all screens.
Results were reviewed with the providers and the office manager. The office manager has received feedback from an ob/gyn office stating that one of their
patients was screened at the office and was seen for follow-up by them. They expressed gratitude that our office was offering PPD screening. There was on
mother who responded yes to question 10 on the EPDS. The response was “sometimes” to the question of self-harm. The mother was accompanied by her
spouse and the mother’s primary-care giver was contacted while the provider was in the exam room and a follow-up appointment was scheduled for the following
day. The mother left the office with resources, accompanied by her spouse, and with instructions on seeking emergency care as indicated. All providers
expressed satisfaction with the screening process.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
Implementation of the project to continue with all providers screening in the next cycle.
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PDSA Cycle 9
PDSA Worksheet for Testing Change
Aim: Continue screening for PPD with all providers at 80% of eligible visits for two weeks.
Every goal will require multiple smaller tests of change
Describe your first (or next) test of change:
Continuation of PPD screening with all providers participating

Person
responsible
DNP student
CPNPs
MDs

When to be
done
5/30/17

Where to be
done
office

Person
responsible

When to
be done

Where to be
done

DNP
student/office
manager and
providers

6/9/17

office

Plan
List the tasks needed to set up this test of change
Review results with providers and office manager
Review project outcomes and plans for sustainability
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Predict what will happen when the test is carried out

Measures to determine if prediction succeeds

Providers will screen for PPD, document results, and provide
appropriate resources/referrals at greater than or equal to 80% of
eligible well-child visits

Number of eligible mothers screened will be compared to actual
number of mothers screened

Screening for PPD will continue after completion of the project

Documentation of results and appropriate resources/referrals in the
EMR

Do

Describe what actually happened when you ran the test
All providers are involved in the project at this time. Data was collected by retrospective chart review. Project outcomes were reviewed with all
providers and the office manager. Plans for sustaining PPD screening were discussed.
Study

Describe the measured results and how they compared to the predictions
49 mothers were identified as eligible to screen and 21 screens were completed. Documentation in the EMR was completed for all screens.
Results were reviewed with the providers and the office manager. During this cycle the two front desk staff were on vacation on alternate weeks. The person who
filled in for them was not familiar with giving eligible mothers the EPDS to complete which resulted in fewer mothers having the opportunity to complete the screen.
There was on mother who responded yes to question 10 on the EPDS. The response was “sometimes” to the question of self-harm. The mother was
accompanied by her spouse and the mother’s primary-care giver was contacted while the provider was in the exam room and a follow-up appointment was
scheduled for the following day. The mother left the office with resources, accompanied by her spouse, and with instructions on seeking emergency care as
indicated. While reviewing preliminary project outcomes with providers, the office manager, and staff, it was agreed unanimously to continue offering PPD
screening in the office. The office manager had already spoken with the provider who had refused to screen earlier in the project and established clear
expectations moving forward.
Act

Describe what modifications to the plan will be made for the next cycle from what you learned
PPD screening to continue with all providers as established in the project.
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Appendix L
Data Collection Tool
Data Collection Tool (Retrospective)
Client
number

Date
of
Visit

Age

Race

G

P

Marital
Status

Years
of
School

Method
of
Infant
Feeding

Completed
Weeks of
Gestation

Insurance
Type
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Result of
Screening
(+/-)

Documentation
of Review of
Screening
(Y/N)

Documentation of
Resources/Referral
Provided
(Y/N)

1

(+/-)

(Y/N)

(Y/N)

2
3

(+/-)
(+/-)

(Y/N)
(Y/N)

(Y/N)
(Y/N)

4

(+/-)

(Y/N)

(Y/N)

5
6

(+/-)
(+/-)

(Y/N)
(Y/N)

(Y/N)
(Y/N)

7

(+/-)

(Y/N)

(Y/N)

8
9

(+/-)
(+/-)

(Y/N)
(Y/N)

(Y/N)
(Y/N)

10
11
12

(+/-)
(+/-)
(+/-)

(Y/N)
(Y/N)
(Y/N)

(Y/N)
(Y/N)
(Y/N)

13
14

(+/-)
(+/-)

(Y/N)
(Y/N)

(Y/N)
(Y/N)

15

(+/-)

(Y/N)

(Y/N)

